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ABSTRACT 
DECIPHERING A POTENTIAL CYTOPROTECTIVE ROLE OF NOVEL HEAT SHOCK 
RESPONSIVE PROTEINS USING A PROTEOMIC APPROACH. 
C.P Kimar 
M.Sc. thesis, Department of Biotechnology, Faculty of Science, University of the Western Cape, 
South Africa. 
Myocardial infarction, commonly known as a heart attack, is a condition where the blood supply 
to the heart tissue is cut off, starving the tissue from oxygen and nutrient supply, with consequent 
lethal damage to the heart tissue. This damage is as a result of the death of cardiomyocytes. 
Numerous studies demonstrated that the death of these cells is as a result of programmed cell 
death or apoptosis. Heat shock proteins can protect cardiomyocytes against cell death by 
inhibiting apoptosis. For this reason heat shock responsive proteins are emerging as therapeutic 
targets to suppress cell death in cardiomyocytes during myocardial infarction. RhoE and TIP41 
are also amongst the genes that are upregulated in cardiomyocytes after heat stress. These genes 
do not encode classical heat shock proteins. The question that arises is whether the induction of 
RhoE during heat stress in cardiomyocytes has any cytoprotective role. This research project 
aims to investigate the potential cytoprotective role of RhoE and TIP41 in rat cardiomyocytes. 
Mutant cell lines that stably over-express RhoE and TIP41 were generated by transfecting H9c2 
cells with the pcDNA-3.1-TOPO vector containing these genes. DNA transfections were 
performed using the metafectene transfection reagent. Over-expression was investigated using 
Western blot analysis. The mutant cell lines were treated with ceramide and camptothecin for a 
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period of 24 hours and cell viability was assessed by the MTT assay. Two dimensional 
proteomic analysis was carried out to compare the proteomes of H9c2 and H9c2 cells that    
over-express RhoE. This research demonstrates that both RhoE and TIP41 are induced in 
response to heat stress and that the over-expression of RhoE is able to protect H9c2 against 
camptothecin induced cell death. Furthermore a proteomic 2D analysis demonstrates differential 
protein expression between H9c2 cells and H9c2 that over-express RhoE. Proteomic analysis 
demonstrates that the over-expression of RhoE leads to the down-regulation of Rho-GDI α. It 
can be concluded from this study that the expression of RhoE in response to heat shock is a 
cytoprotective event. The mechanism of cytoprotection is likely to involve Rho-GDI α. 
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1.1 Myocardial infarction and cardiac ischemia 
Myocardial infarction (MI), commonly known as a heart attack is a major concern throughout 
the world. This condition results in the death of approximately 37 people every day (Bradshaw et 
al., 2000). During myocardial infarction oxygen and nutrient rich blood flow is temporarily cut 
off from the heart, a condition also known as cardiac ischemia. Restoration of blood flow to the 
myocardium (also known as reperfusion) can restore metabolic and ionic imbalances. However, 
both ischemia and reperfusion may result in irreversible damage to the cardiomyocytes (Kyu 
Kim et al., 2011) through apoptosis or necrosis of these cells. These cells cannot be replaced. 
The consequence of this is that part of the heart muscle dies which affects the normal functioning 
of the heart. The recovery of the myocardium following an ischemic insult is mainly dependant 
on the extent of the ischemic period (Murphy and Steenbergen, 2008). The longer the period of 
ischemia the higher the chance of irreversible damage to the myocardium (Suleiman et al., 
2001). Over the past decades it has become clear that mechanisms of cytoprotection to 
cardiomyocytes can be manipulated to delay injury to these cells during MI (Murphy and 
Steenbergen, 2008).   
 
1.1.1 Ischemic preconditioning 
Ischemic preconditioning (IP) is an in vivo induced experimental procedure in which nutrient and 
oxygen rich blood to the heart is briefly interrupted. This procedure renders cardiomyocytes 
resistant to the cytotoxic effects of subsequent ischemia/reperfusion induced stress (Piper and 
Ladilov, 1997). IP was first described in a study performed in 1986 by Murrey et al. In this study 
the occlusion of a major coronary artery induced ischemic injury in a dog (Murrey et al., 1986). 
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These authors also demonstrated that 20 minutes cycles (i.e. 4  5 minute intervals) of ischemia 
with intermittent reperfusion (this procedure is also known as cardiac ischemic preconditioning) 
results in the protection of the heart tissue against subsequent ischemia/ reperfusion damage 
(Guisasola et al., 2006). The IP phenomenon enables protection of cardiomyocytes by preserving 
the function of the mitochondria and decreasing oxidative stress, which occurs during ischemic 
reperfusion injury (Kyu Kim et al., 2011). IP studies have been used extensively to demonstrate 
various functional and physiological responses of the myocardium and cardiomyocytes related to 
ischemic reperfusion injury (Murphy et al., 2008). The mechanism of IP has been widely 
investigated and over the last decade in search for prevention and novel treatments for MI. 
 
1.1.2. Heat shock preconditioning 
Heat shock response is one of the most important pro-survival mechanisms of cells. Heat shock 
response was first described in 1962 by Feruccio Ritossa. Ritossa observed enlargement of 
chromosomes in the salivary glands of Drosophila melanogaster (which was termed “heat shock 
puffs”) in response to exposure to heat (Csermely and Yahara, 2002). Heat shock response is a 
biochemical response of cells when exposed to mild heat stress, i.e. an increase in temperature of 
approximately 3 – 5°C above basal level (Lindquist, 1986). Mammalian species have developed 
several mechanisms to overcome or deal with stressful conditions, such as the temporary 
modification of gene expression in order to adapt to the altering environment as well as changing 
the cellular structure and function to withstand more permanent unfavorable conditions. Heat 
stress results in the accumulation of misfolded proteins, which activates the Unfolded Protein 
Response (UPR) in cells (Samali and Cotter, 1996; Fulda et al., 2010).  
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During the UPR, the cells temporarily increase the expression of various chaperone proteins 
(also referred to as stress proteins), which are able to restore the homeostasis within the cell. The 
cells also inhibit the expression of proteins involved in translation and transcription. As result the 
cells grow slower and adapt to the elevated temperature, a phenomenon is known as 
thermotolerance or heat shock preconditioning. Thermotolerant cells are more resistant to toxic 
insults, for example oxidative stress (Samali and Orrenius, 1998). Heat shock preconditioning 
can be used as an in vitro experimental method to study cytoprotection in cardiomyocyte cells. 
Heat shock preconditioning protects cardiomyocytes against apoptosis or programmed cell death. 
 
1.2. Apoptosis 
Apoptosis, a highly regulated form of cell death. It is an important process which plays a role in 
normal embryological development and in maintaining homeostasis by removing excess or 
damaged cells (Gill et al., 2006). Apoptosis contributes to the sculpturing of organs and tissues 
(Meier et al., 2000). Apoptosis is triggered by various stimuli such as ultraviolet radiation, 
oxidative stress and DNA damage (Rajesh et al., 2009). It is characterized by cell shrinkage, 
chromatin condensation and plasma membrane blebbing. During apoptosis, dead or damaged 
cells are removed without causing inflammatory response or damage to neighboring cells (Gill et 
al., 2006). However, defects in the regulation of apoptosis lead to a number of diseases such as 
cancer, ischemic injury and neurodegenerative diseases (Benoist and Mathis, 1997). Three major 
apoptotic pathways which lead to the activation of cysteine aspartic acid-specific proteases 
(caspases) apoptosis and ultimately cell death exist namely, the extrinsic, intrinsic and the 
endoplasmic reticulum (ER) stress signaling pathway. Caspases are responsible for the 
morphological changes of apoptotic cells and they are fundamental to the execution mechanism 
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of apoptosis. Caspases are either classified as initiator or effector caspases. Initiator caspases 
initiate the disassembly of cells in response to apoptotic stimuli and effector caspases inhibit 
proteins that protect cells from apoptosis (Nicholson, 1999). The extrinsic pathway is initiated 
through cell surface receptors, the intrinsic pathway involves the mitochondria and the ER stress 
signaling pathway is as a result of perturbation of endoplasmic reticulum homeostasis (Gill et al., 
2006). 
 
The extrinsic pathway is also referred to as the death signaling pathway of apoptosis. Death 
receptors belong to the tumour necrosis factor (TNF) family and are able to transmit apoptotic 
signals across the cell membrane. The death receptor family include the TNF, Fas, TRAIL-R1 
and TRAIL-R2. Apoptosis is initiated through the binding of death receptors to a specific ligand. 
Once the ligand (FasL) binds the Fas receptor, Fas Associated Death Domain (FADD) 
(Chinnaiyan et al., 1995) recruits pro-caspase-8 or 10 through its interaction with the death 
effector domains (DED), which results in the formation of the Death Inducing Signaling 
Complex (DISC) (Kischkel et al., 1995). This results in the oligomerization and auto-activation 
which cleaves Bid which is translocated to the mitochondria. The above activates the 
mitochondrial pathway followed by the activation of caspase-3 which leads to apoptosis.  
 
The intrinsic pathway, also known as the mitochondrial signaling pathway. The mitochondria is 
known to play a role in energy metabolism and in the regulation of apoptosis. Damage of the 
mitochondria may occur through cytotoxic agents in particular those which cause oxidative stress 
(Samali and Orrenius, 1998). This results in the permeabilisation of the outer mitochondrial 
membrane and the release of pro-apoptotic proteins into the cytosol. The pro-apoptotic proteins 
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include cytochrome c, apoptosis inducing factor (AIF), pro-caspases and Smac/DIABLO 
(Srinivasula et al., 2000). Cytochrome c then forms a complex in the cytosol with apoptosis 
protease activating factor 1 (Apaf-1) and pro-caspase-9 in the presence of dATP/ATP. This 
complex is known as the apoptosome, which leads to the cleavage of caspase-9 and the 
activation of caspase-3 (Gill et al., 2006). 
 
The ER stress signaling pathway is the third mechanism of caspase activation. The ER functions 
in the storage of calcium and in post-translational modifications of proteins which takes place in 
the lumen. ER stress can be triggered by diseases (stroke and diabetes) which results in a calcium 
imbalance and an increase in misfolded proteins within the cell. To overcome the effects of ER 
stress the cell acquires protective strategies known as the Unfolded Protein Response (UPR). 
UPR involves the induction of signaling pathways, involved with the promotion of cell survival. 
If signaling pathways are not able to restore homeostasis then apoptosis is initiated. ER stress 
results in an increase in calcium, which leads to the activation of calpain. The activated calpain 
cleaves and activates Bid causing it to translocate to the mitochondria which leads to the 
activation of the mitochondrial pathway. Calpain can activate caspase-12 which activates other 
caspases, ultimately leading to apoptosis (Gill et al., 2006).  
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1.3. The Heat shock protein Family 
Heat shock proteins (Hsps) are a family of highly conserved stress response proteins also 
referred to as molecular chaperones, which are ubiquitous in nature (Whitley et al., 1999). They 
were discovered from chromosomal puffs in the salivary glands of Drosophilia. The expression 
of Hsps is important for cell survival in response to stress, but these proteins also play a key role 
under normal physiological conditions such as embryonic development (Stephanou and 
Latchman, 2011). They can be induced by a variety of stress insults or conditions which include 
heat, oxygen deprivation and nutrient depletion. Hsps act as molecular chaperones by assisting in 
the refolding of misfolded proteins and assist in their removal in the event of irreversible damage 
(Sreedhar and Csermely, 2004). Hsps represent approximately 1 – 2% of the total protein content 
in the cell under normal physiological conditions (Stephanou and Latchman, 2011). Hsps are 
divided and named into subfamilies according to their size and function, e.g. the Hsp110, Hsp90, 
Hsp70, Hsp60 and the small Hsp family. Certain Hsps are constitutively expressed, but the 
expression levels of these proteins can increase in response to stress (Concannon et al., 2003).  
 
The high molecular Hsps, namely Hsp110, Hsp90, Hsp70 and Hsp60 are ATP-dependant 
chaperones, therefore these proteins require co-chaperones to alter their confirmation and ATP 
binding (Garrido et al., 2001). Certain Hsps such as Hsp90, Hsp60 and Hsp10 are expressed 
under basal conditions. However, stressful stimuli can increase the expression levels of these 
proteins (Morimoto et al., 1996). Once Hsps are synthesized they bind to proteins and assist in 
refolding of misfolded proteins, or target them for degradation (Stephanou and Latchman, 2011).  
The most extensively studied Hsps are Hsp90, Hsp70 and the small Hsps (Sreedhar, Vanathi and 
Paithankar, 2010). Hsp90 exists in two isoforms, Hspα and Hspβ. The Hsp90 family consists of 
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ATP-dependant chaperones, such as Hsp90a, Hsp90b and Grp94 (Csermely et al., 1998). Hsp90 
has been shown to associate with various signaling proteins such as the steroid receptor and 
Myod which are ligand-dependant and ligand-independant transcription factors, respectively. 
The main chaperone role of Hsp90 is in the promotion and maturation of transcription factors 
(Stephanou and Latchman, 2011).  
 
Hsp60 is a constitutively expressed protein situated in the mitochondrial matrix, although 
approximately 15 – 20% of the protein is located in the cytosol. Hsp60 plays a role in the folding 
of mitochondrial proteins and aids in the proteolytic degradation of misfolded proteins in an 
ATP-dependant manner (Chen et al., 1997). Hsp60 was first thought to be a mitochondrial 
protein, but studies have shown that two forms of Hsp60 exist, one in the mitochondria and the 
supplementary in the cytoplasm (Sreed Sreedhar, Vanathi and Paithankar, 2010).  The regulation 
of Hsp60 is dependant on Hsp10 which is also located in the mitochondria, where these proteins 
play a role in protein folding of multimeric enzymes (Gill et al., 2006). Two Hsp10 molecules 
bind to Hsp60 in the presence of ADP (Chen et al., 1997). The role of Hsp60 and Hsp10 remains 
controversial. In certain studies it has been suggested that in Jurkat cells, Hsp60 and Hsp10 could 
possibly act as pro-apoptotic proteins (Samali et al., 1998; Xanthoudakis et al., 1999). On the 
other hand studies in cardiomyocytes suggest that Hsp60 and Hsp10 are cytoprotective (Lau et 
al., 1997; Kirshhoff et al., 2002). 
 
The most extensively studied Hsp with regard to cytoprotection is Hsp70 (Gill et al., 2006). It 
has been established that the induction of certain Hsps, such as Hsp70 and Hsp27 confers 
protection against apoptotic cell death (Gill et al., 2006). Hsps that belong to the Hsp70 family 
 
 
 
 
8 
 
are involved in both the primary responses to various insults as well as having the role of a 
chaperone. The cognate form of Hsp70 is Hsc70 which differs from the inducible form, 
Hsp70.The Hsp70 family is the most abundant of the Hsps and consists of 4 members, the 
Hsc70, Hsp70, BIP, Mtp70. Hsc70, BIP and Mtp70 are present under basal conditions, whereas 
Hsp70 is induced in response to stress (Gill et al., 2006). Hsp70 is an inducible Hsp and has been 
demonstrated to protect cells against apoptosis in response to a variety of stressors (Samali and 
Cotter, 1996). Hsps are able to achieve this by the inhibition of the apoptotic pathways and by 
pro-survival activities such as refolding of misfolded proteins and as a result prevent protein 
aggregation (Hartl and Hayer-Hartl, 2002). Hsp70 has the ability to inhibit apoptosis at various 
levels in the apoptotic pathways. It has been demonstrated that Hsp70 can interact with death 
receptors TRAIL-R1, and TRAIL-R2 which results in the inhibition of DISC formation and 
apoptosis (Guo et al., 2005).  
 
Hsps are of great interests as imperative regulators of the apoptotic pathway with their ability to 
interact with caspases and therefore promote and enhance cell survival (Figure 1.1).  
The subfamily of small Hsps, namely Hsp27 are found in nearly all organisms and its expression 
is generally very low at basal level (Concannon et al., 2003). There are various mechanisms 
whereby Hsp27 can inhibit apoptosis (Figure 1.1). Hsp27 is involved in the regulation of 
cytoskeleton (Liang and McRae, 1997). Correct synthesis and assembly of cytoskeletal elements 
are imperative for normal functioning and if this does not take place it could be detrimental to 
cell survival. Hsp27 has the ability to associate with cytochrome c in the cytosol and in turn 
prevent apoptosome formation (Concannon et al., 2001; Bruey et al., 2000).  
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Figure 1: Sites where Hsp70 and Hsp27 can attenuate apoptosis. Hsp70 can inhibit Fas receptor pathway by binding 
to ASK1 in turn inhibiting downstream signaling transduction. In addition Hsp70 is able to inhibit the JNK signaling 
pathway by interacting with IKK. Hsp70 can bind to pro-forms of the effector caspases-3 and -7 and therefore 
inhibiting their activation. A target of Hsp27 is the Fas receptor pathway, in which Hsp27 binds to Daxx. Hsp70 and 
Hsp27 are able to affect the mitochondrial pathway by inhibiting the formation of the apoptosome. Hsp70 can 
inhibit the release of cytochrome c from the mitochondria, while Hsp27 can inhibit both cytochrome c and Smac 
release from the mitochondria. Adapted from Gill et al., 2006. 
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1.3.1. The regulation of heat shock protein expression 
The expression of Hsps in higher organisms such as mice and humans are regulated by heat 
shock transcription factors (HSF) (Sreedhar et al., 2010). The induction of Hsps is reliant on the 
activation of these transcription factors. The HSFs associate with the heat shock element (HSE) 
in the promoters of genes that encode Hsps (Akerfelt et al., 2010). There are four HSFs that have 
been characterized, namely HSF1 – HSF4. However, HSF3 has only been reported in avian cells.  
HSF1 and HSF3 are involved in the regulation of Hsps in response to heat stress, while HSF2 
and HSF4 regulate Hsp expression under basal conditions, as well as in response to biological 
processes such as immune activation and cellular differentiation (Akerfelt et al., 2010). Stimuli 
that result in the change of Hsp gene expression at basal level are poorly understood (Stephanou 
and Latchman, 2011).  Induced expression of HSF is not required for the activation of stress 
response, although post-translational modifications initiate the activation of HSF (Sarge et al., 
1991). HSF are constitutively expressed in cells and were shown to be associated with Hsp70 or 
Hsp90 or both in their latent or active forms. HSF1 interacts with HSF1 interaction with Hsp70 
or Hsp90 can negatively regulate HSF leading to the transcriptional activation of heat shock 
genes (Sreedhar et al., 2010).  
 
Under normal physiological conditions, HSF1 exists as an inactive non-DNA binding monomer. 
Once activated it forms active homotrimers, which translocates to the nucleus and binds to 
consensus-binding sites which lie within the promoter sequences of Hsps genes (Baler et al., 
1993; Rabindran et al., 1993; Akerfelt et al., 2010; Shi et al., 1998). HSE’s are characterized by 
at least three inverted pentameric repeats nGAAn in sequential order to form a 15-bp HSE motif 
nGAAnnTTCnnGAAn (Xiao et al., 1991).  
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Kinases which are accountable for the phosphorylation of HSF1 on serine sites are the glycogen 
synthase kinase and the c-Jun N-terminal kinase (JNK) (Xavier et al., 2000; Park and Liu, 2001). 
The role of HSF1 has been demonstrated by cells which lack HSF1 which resulted in defects 
during the induction of Hsps in response to thermal stress. Cells lacking the HSF1 were highly 
susceptible to cell death in response to thermal stress (Xiao et al., 1999). HSF1 is constitutively 
expressed in various cell types, and is in a dormant state in the absence of stressful insults.  
 
HSF2 is involved in the regulation of Hsps during normal physiological conditions. HSF2 exist 
as two isoforms, HSF2α and HSF2β, which result from alternative splicing (Goodson et al., 
1995). HSF2α and HSF2β are primarily expressed in adult tissue and embryonic tissue, 
respectively. However, HSF2 acts both positively and negatively to HSF1 mediated upregulation 
of Hsp expression. This suggests that HSF2 may play an active role in the transcriptional 
regulation of thermal stress (Akerfelt et al., 2010). HSF2 has the ability to modulate heat shock 
response by the formation of heterotrimers in association with HSF1 in nuclear stress bodies 
once bound to satellite III repeats (Sandqvist et al., 2009). Studies have shown that the depletion 
of HSF1 affects the localization of HSF2 to nuclear stress bodies, therefore destroying the  
stress-induced synthesis of satellite III transcripts. 
 
1.3.2 The cytoprotective effect of heat shock proteins 
It has been established that there are several mechanisms whereby the expression of Hsps leads 
to cytoprotection. The latter corresponds with increasing resistance to cell death (Samali and 
Orrenius, 1998). The mechanism whereby Hsps confer cytoprotection is relevant in a number of 
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disease states such as the cytoprotective effects of Hsp70 in various human diseases such as MI, 
inflammation and infection. The expression of Hsps can be beneficial or damaging depending on 
the disease (Gill et al., 2006). Hsps, namely Hsp70, Hsp27 and Hsp90 are able to inhibit 
apoptosis by associating with pro-apoptotic proteins. These Hsps are up-regulated in cancer cells, 
which could play a pivotal role in oncongenesis, and in turn limit the effectiveness of cancer 
therapy (Jaattela, 1999). The over-expression of Hsp70 and Hsp27 has been shown to increase 
tumor growth in rodent cells in syngenetic hosts (Jaattela, 1995; Garrido et al., 1995), conversely 
the depletion of Hsp70 was shown to contribute to tumor regression (Jaattela et al., 1998; 
Guruxani et al., 2001). Therefore, the increased expression of Hsps in certain forms of cancer 
promote tumourgenicity and confer resistance to apoptosis (Jaattela, 1998).  
 
1.3.3 Hsps as therapeutic targets  
Researchers regard Hsps as a therapeutic target in the treatment of cancers and cardiovascular 
diseases. In MI, the induction of Hsps results in the survival of cardiomyocytes and can therefore 
be beneficial (Gray et al., 1999). Hsps play a role in cytoprotection in which they allow cells to 
survive under stressful conditions, enabling cells to adapt to changes in environmental 
conditions. Studies have demonstrated that an increased expression of Hsps (Hsp70, Hsp60, 
Hsp10 and Hsp90) results in cytoprotection against apoptosis. The cytoprotective properties of 
small Hsps also draw much attention. In one study the over-expression of Hsp27 in H9c2 (rat 
cardiomyocytes) correlated with cell survival in response to heat stress (Zhu and Wang, 2005).  
In 1988 a study by Currie et al demonstrated that the over-expression of Hsp70 in response to 
ischemic injury confers protection against cell death. Hsps are constantly been investigated as 
potential therapeutic tools in the treatment of MI.  
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The expression of these proteins is also advantageous in organ transplant surgery, in which Hsps 
reduce damage and organ rejection during an organ transplant (Perdrizet et al., 1993).  
 
Since the over-expression of Hsp90 has been linked to cancer, Hsp90 inhibitors are of 
therapeutic potential in fighting cancer (Smith, 2009). Enzo Life Sciences have released novel 
inhibitors, which specifically inhibit Hsp90. These novel Hsp90 inhibitors function like kinase 
inhibitors in which they bind to ATPase site of Hsp90.  
 
On the other hand the expression of Hsps can be induced by various drugs, which can serve as a 
therapeutic tool. Bimoclomol for example is a hydroxylamine derivative that was shown to 
induce the expression of Hsp70 in HeLa cells and rat cardiomyocyte cells. The latter resulted in 
an increased expression of Hsp70, which was also associated with increased cytoprotection 
(Vigh et al., 1997). Hsps are emerging targets in developing cytoprotective therapeutic strategies 
to protect the cardiomyocytes during MI.  
 
1.4. Novel heat shock responsive proteins 
The identification of new heat shock responsive proteins and studying the molecular mechanisms 
of known heat shock proteins receives much attention by researchers. A previous study using the 
Suppression Subtractive Hybridization technique demonstrated that RhoE and TIP41 are 
upregulated in H9c2 cells (rat cardiomyocytes) after heat shock treatment (Gill, 2004). To date, it 
is not known whether the proteins encoded by these genes are also upregulated by heat shock and 
whether the proteins have any cytoprotective role. An investigation into the role that these two 
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proteins play in heat shock and potentially also cytoprotection is of interest as it could lead to 
new therapeutic strategies to prevent cardiomyocyte injury during MI.  
 
1.4.1. RhoE 
1.4.1.1. The Rho-GTPase Family 
Rho-GTPases are a family of proteins that belong to the Ras superfamily of GTPases, which 
includes Rnd1, Rnd2 and Rnd3/RhoE. These proteins are key regulators of various cellular 
biological processes such as cytoskeleton formation, cell cycle progression, gene transcription 
and gene trafficking. Rho proteins rotate between two conformational states, namely the active 
and inactive GTP-binding state. RhoE is only found in the GTP-binding form (Li et al., 2009). 
Approximately 22 members of the Rho family are found in humans and the best characterized 
human Rho proteins are Rho A, B and C, Rac 1, 2 and 3 and Cdc42 (Riento et al., 2005). RhoE, 
also known as Rnd3 is a small GTP-binding protein, which plays an important role in actin 
reorganization (Zhang et al., 2007). Rnd1, Rnd2 and Rnd3/RhoE form a divergent branch of Rho 
proteins (Riento et al., 2005). RhoE and Rnd1 expression was shown to cause loss of actin stress 
fibres (Guash et al., 1998; Nobes et al., 1998) and also correlates with the increase of cell 
migration (Guash et al., 1998). Another study showed that RhoE and Rnd1 expression inhibits 
cell cycle progression (Villalonga et al., 2004). The expression of RhoE have been shown to be 
regulated in response to various factors, such as platelet-derived growth factor (Riento et al., 
2003), hepatocyte growth factor (Tanimura et al., 2002) and upon the activation of Raf in 
MDCK cells (Hansen et al., 2000).  
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RhoE was shown to interact with Rho-associated kinase I (ROCK I). ROCK I phosphorylate 
various cellular proteins, including RhoE (Riento et al., 2005). Depending on the 
phosphorylation status RhoE, it is either present in the cytosol (phosphorylated) or on the 
membrane (dephosphorylated). The binding of ROCK I to RhoE, increase the stability of RhoE 
(Riento et al., 2005). It was suggested that RhoE could be part of a negative feedback loop in 
which it inhibits ROCK I, thus inhibiting the binding of ROCK I to other target proteins. It is 
therefore possible that phosphorylation plays a vital role in the mechanism by which RhoE 
function in relation to the disruption of actin filaments (Riento et al., 2005). 
 
1.4.1.2. RhoE and carcinogenesis 
Previous studies suggest that the Rho family plays an important role in signal transduction 
pathways that were implicated in carcinogenesis (Zhang et al., 2007). The expression of RhoE 
was found to be either absent or weak in normal bronchial epithelial cells compared to tumor 
tissues, where RhoE was found to be over-expressed (Zhang et al., 2007). Zhang et al describes 
RhoE as a potential biomarker for cancer, since high RhoE expression levels correlate with poor 
survival rates in cancer patients. The study found that the over-expression of RhoE was found in 
the cytoplasm of lung cancer cells compared to non-tumor cells in which the expression of RhoE 
was undetected (Zhang et al., 2007). A study conducted by Trojan et al illustrated that the 
expression of RhoE was found to be significantly higher in prostate cancer cell lines which had 
high metastatic potential, which possibly suggests that RhoE plays a role in metastatic cancers 
(Trojan et al., 2005), which correlates well with the finding that RhoE disrupts actin filaments.  
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It was also shown that RhoE is able to inhibit cell proliferation, induce G1 arrest and negatively 
regulate the Ras-Raf-mitogen-activated protein kinase pathway, which inhibits Ras-induced 
transformation after RhoE was microinjected into cells for an extended period of time 
(Villalonga et al., 2004). Due to the latter conflicting results, it can be suggested that RhoE may 
function via two mechanisms.  RhoE can function as either a tumor promoter or suppressor, 
where the latter is dependent on the cell type. The second mechanism involves the tumor 
promoter and suppressor function of RhoE being concentration dependant. The induction or over 
expression of RhoE in prostate cancer cell lines inhibited the growth of cancer cells which 
resulted in G2/M arrest (Zhang et al., 2007). Abberrant levels of RhoE have been shown in 
various human tissues. A study by Bektic et al demonstrated reduced expression of RhoE in 
prostate cancer compared to benign prostate. On the other hand lung cancer tissue had a higher 
expression level of RhoE compared to reduced expression in normal lung tissue. RhoE was 
observed to be statistically significant independent prognostic predictor in reduced cancer 
survival of individuals with lung cancer. The above implies the dual role of RhoE in various cell 
types (Zhang et al., 2007).  The hypothesis that the function of RhoE is concentration dependant 
was demonstrated by Lokeswar et al where it was shown that expression of HYALI results in 
slow tumor cell growth, the inhibition of tumor growth and the induction of apoptosis. Similar 
results were observed by Zhang et al where patients with lung cancer which had strong RhoE 
expression lead to increased survival compared to patients with moderate RhoE expression. They 
also observed that patients with moderate RhoE expression had reduced chance of survival 
compared to those with negative RhoE staining. Therefore, Zhang et al suggest that RhoE 
function may be concentration dependant (Zhang et al., 2007).   
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A study by Zhang et al concluded that the over-expression of RhoE could possibly be the 
foundation of potential treatment of non-small cell lung cancer, as its over-expression correlated 
with lengthening patient survival (Zhang et al., 2007). The expression of RhoE is down regulated 
in prostate cancer in comparison to normal prostatic cells (Li et al., 2009). The pro-apoptotic 
protein, Bax was shown to promote multi-drug resistance of gastric cancer. In a study conducted 
by Li et al. (2009), RhoE suppressed Bax, which lead to the survival of gastric cancer cells. A 
study conducted by Ongusaha et al. (2006) illustrated that silencing the induction of RhoE in 
response to genotoxic stress resulted in stress fibre formation and an increase in apoptosis. On 
the other hand p53 mediated induction of RhoE in response to DNA damage resulted in the 
inhibition of ROCK-I mediated apoptosis. RhoE is likely to function by the regulation of ROCK-
I signaling in order to control the balance between cell survival and cell death in response to 
genotoxic stress (Ongisaha et al., 2006). In a recent study RhoE was shown to be upregulated 
after heat shock pretreatment of the rat cardiomyocyte cell line H9c2 cells (Gill, 2004). To date it 
has not been demonstrated whether the over-expression of RhoE is cytoprotective. 
 
1.4.2. TIP41 
1.4.2.1. The role of TIP41 in the TOR signaling pathway 
Cells respond to external stimuli by either increasing or decreasing the synthesis of 
macromolecules (DNA, protein and lipids). Cell growth involves the equilibrium between 
positive regulation of anabolic processes and negative regulation of catabolic processes. In 
proliferating cells, growth is associated with the cell cycle where cells multiply in mass by 
increasing the synthesis of macromolecules before dividing (Hall, 2005). During stressful insults, 
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such as nutrient and growth factor depletion cells can sequester a constituent of the cytoplasm, 
which include organelles within vesicles. These vesicles are referred to as autophagosomes 
(Yorimitsu et al., 2009). 
 
Target Of Rapamycin (TOR) is a protein kinase whose activity is dependant on nutrient 
availability within the cell (Jacinto et al., 2001). The TOR signaling pathway plays a pivotal role 
in the induction of autophagy and the promotion of cell growth in eukaryotes (Gonzalez et al., 
2009). The TOR pathway is active in yeast cells in the presence of sufficient nutrients, whereas 
the pathway is inactivated when nutrient availability is low. TOR drives the expression of 
various genes that are transcribed by the three RNA polymerases (Gonzalez et al., 2009).  
 
These changes in the TOR pathway activity was demonstrated by transcriptional studies on DNA 
microarray using rapamycin treated cells (Cardenas et al., 1999). Rapamycin is a macrolide 
antibiotic commonly used as an immunosuppressive drug to inhibit TOR activity (Panieri et al., 
2010). 
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Figure 1.2: TIP41 in the TOR signaling pathway (Jacinto et al., 2001) 
 
 
TIP41 is a constituent of the TOR signaling pathway. The TOR signaling pathway controls cell 
growth in response to nutrient deprivation through various effectors (Jacinto et al., 2001). The 
TOR effectors are the TAP42-mediated inhibition of type 2A-related phosphatase SIT4. TOR 
promotes the organization of TAP42 to SIT4 in the presence of sufficient nutrients which leads 
to the inhibition of SIT4. TOR is inactivated upon nitrogen deprivation or rapamycin treatment. 
This leads to the release of SIT4 from TAP42 and in turn SIT4 is activated. Thereafter, SIT4 is 
dephosphorylated which leads to the activation of various target proteins, namely transcription 
factor GLN3 and Ser/Thr kinase NPR which are involved in the uptake of secondary nitrogen 
sources (Schmidt et al 1998). TAP42 is an essential protein which binds to PP2A catabolic 
subunits therefore control various downstream effectors. TIP41 plays a role in the TOR pathway 
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by inhibiting TAP42 through its interaction with TAP42, therefore negatively regulating the 
TOR pathway. However, the association between TIP41 and TAP42 is also regulated by the 
TOR pathway (Jacinto et al., 2010). SIT4 dephosphorylates TIP41 either directly or indirectly 
and this improves the TIP41 and TAP42 association. Seemingly it appears that TIP41 is part of a 
feedback loop which could explain the reason for the extremely rapid dephosphorylation of 
NPR1 as a result of rapamycin treatment (Schmidt et al.,1998). 
 
1.5. The aim of this study 
The aim of this research project was to determine whether RhoE and TIP41 is induced by heat 
stress and to determine if the over-expression of RhoE and TIP41 has any cytoprotective 
function in H9c2 cells. If these genes are found to be cytoprotective it could shed light on the 
mechanism of cytoprotection as well as lead to novel therapeutic applications with further 
research. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1.  Materials used and suppliers 
 2.1.1. List of utilized kits  
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2.11. Purification of pcDNA 3.1-RhoE, pcDNA 3.1-TIP41 and pcDNA 3.1-Hsp27 on Cesium                 
         chloride /Ethidium bromide gradients. 
2.12. Transfection of pcDNA 3.1-RhoE, pcDNA 3.1-TIP41 and pcDNA 3.1-Hsp27 into H9c2   
          cells. 
2.13. Analysis of the cell viability 
2.14.  Analysis of the cell viability of heat shock preconditioned H9c2 cells 
2.14.1. Analysis of cell viability of heat shock preconditioned H9c2 cells 
2.15. Protein extraction 
2.16. 1D SDS-Polyacrylamide Gel Electrophoresis 
2.16.1. Gel preparation 
2.16.2. Sample preparation and gel loading 
2.16.3. Gel staining 
2.17. Analysis of RhoE, TIP41 and Hsp27 expression by Western blot analysis. 
2.17.1. Blot transfer of proteins onto PVDF membrane 
2.17.2. Analysis of RhoE, TIP41 and Hsp27 
2.17.3. Development of the film 
2.18.  Two dimensional Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (2D   
          SDS-PAGE) 
2.18.1. Reswelling of IPG strips 
2.18.2. Isoelectric focusing (IEF) 
2.18.3. Equlibration of strips 
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2.18.4. Separation of proteins in the second dimension 
2.19.  PDQuest
™ 
Basic software image analysis 
2.19.1. Gel image analysis 
2.20.  Spot cutting and trypsinization 
2.21.  Mass spectrometry for protein identification 
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  CHAPTER 2: 
2.1. Materials used and Suppliers  
Materials                                                                                    Suppliers 
Acetic Acid                                                                                  Merck 
Acetone                                                                                        Merck  
40 % acrylamide Bis Solution 37:5:1                                           Serva 
Actin Antibody                                                                            Santa Cruz 
Agarose                                                       Whitehead Scientific  
Ammonium Persulphate (APS)                                                   Merck 
Ampholytes                                                                                  Bio-Rad 
Bacteriological agar                                                                     Merck 
Bovine Serum Albumin (BSA)                                                    Roche 
Bradford Reagent                                                                         Bio-Rad 
Bromophenol blue                                                                        Merck 
Cesium Chloride                                                                         Roche 
     3-[(3-Cholamidopropyl) dimethylammino]-                 
      1propanesulfonate (CHAPS)                                                                    Sigma Aldrich   
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     Coomassie Brilliant Blue R-250 (CBB)                                       Bio-Rad 
      CytoBuster
™
 Protein Extraction Reagent                                   Novagen 
Detection Solution                                                                       Thermo Scientific 
Dimethyl dicarbonate                                                                  Sigma 
Dithiothreitol (DTT)                                                                    Fermentas 
3-(4,5-Dimthylthiazol-2-yl)- 2,5- 
Diphenyltetrazolium bromide (MTT Dye)                                  Sigma Aldrich 
Diethylpyrocarbonate (DEPC)                                                    Merck 
Donkey Anti-Goat          Santa cruz 
Donkey Anti-Mouse  Santa cruz 
Dream Taq
™
 DNA Polymerase              Fermentas 
Dulbecco’s Modified Eagle’s Medium (DMEM)                       Invitrogen 
Ethylene Diamine Tetra-acetic acid (EDTA)                              Merck  
Ethanol                                                                                         Merck  
Ethidium Bromide                                                                       Sigma  
Fetal Bovine Serum (FBS)                                                           Invitrogen 
Geneticin (G418)                                                                         Invitrogen 
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6X Gel Loading Buffer                 Fermentas 
      Glycerol                                                                                       Merck 
Glycine                                                                                         Merck 
Hsp27 Antibody                                                                           Santa Cruz 
Hydrochloric Acid                                                                        Merck 
Iodoacetamide                                                                               Sigma 
Isopropanol                   Merck 
Metafectene
™
 Transfection Reagent                                             Biontex Laboratories  
Methanol                                                                                        Merck  
      Nuclease free water                  Fermentas 
Penicillin-Streptomycin                                                                 Invitrogen 
Pfu DNA Polymerase                                                                    Fermentas 
Phosphate Buffered Saline (PBS)                                                 Invitrogen 
Potassium Acetate                  Merck 
Rho8 Antibody                                                                             Santa Cruz 
      Sodium Chloride (NaCl)                                                               Merck 
Sodium Dodecyl Sulphate (SDS)                 Merck 
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    Sodium Hydroxide                          Merck   
   TIPRL polyclonal antibody                                                          Abnova     
   N,N,N’,N’-Tetramethylethylenediamine (TEMED)                     Sigma Aldrich 
   Tris[hydroxymethyl] aminoethane (Tris)                                     Merck 
   Tryptone                                                                                       Merck 
   Trypsin                                                                                         Invitrogen 
   Tween 20                                                                                      Merck 
   V5-Probe                                                                                      Santa Cruz 
   Urea                                                                                              Sigma 
   Yeast Extract                                                                                Merck 
 
2.1.1. List of kits 
First Strand cDNA Synthesis Kit for RT-PCR (AMV)        Roche 
NucleoSpin® TriPrep kit                                                              Macheret-Nagel 
pcDNA
™
 3.1 Directional TOPO
®
 Expression Kit                        Invitrogen 
Reverse Transcription System Kit                                                Promega 
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2.2. Solutions and Buffers 
Ammonium persulphate:  10% stock was prepared in 10ml of distilled water. This solution was 
stored at 4°C. 
Ampicillin: 100mg/ml stock prepared in distilled water and stored at -20°C. 
Coomassie Brilliant Blue (CBB) staining solution I: 50ml of 1.25% CBB stock solution, 10% 
acetic acid, 30% isopropanol. 
CBB staining solution II: 6ml of 1.25% CBB stock solution10% acetic acid, 12% isopropanol, 
2000ml distilled water. 
CBB staining solution III: 6ml of 1.25% CBB stock solution, 10% acetic acid, 2250ml distilled 
water. 
Coomassie staining solution: 0.25g Coomassie Brilliant Blue R 250, 45% methanol and 5% 
acetic acid  
DEPC treated water: 2ml dimethyl dicarbonate dissolved in 2 litres of distilled water. 
Incubated at 22°C overnight and autoclaved.  
Destaining solution: 30% methanol and 10% acetic acid in distilled water 
DTT buffer: 2% (w/v) DTT in SDS equilibration buffer. 
6X Glycerol BPB Gel Loading Buffer: 30% Glucose and 0.3% Bromophenol blue 
GTE solution: 0.05M Glucose, 0.025M Tris, 0.01M EDTA  
Iodoacetamide buffer: 2.5% (w/v) iodoacetamide in SDS equilibration buffer. 
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Luria agar: 10g/l Tryptone, 5g/l Yeast Extract Powder, 5g/l NaCl, 14g/l Bacteriological Agar. 
Luria Broth: 10g/l Tryptone, 5g/l Yeast Extract Powder, 5g/l NaCl.  
Sodium chloride-saturated isopropanol: NaCl was added to isopropanol until completely 
saturated. 
PBS: 13mM NaCl, 2.7mM KCl, 8mM Na2HPO4 and 1.5mM KH2PO4, pH 7.4 
5X Sample buffer: 250mM Tris-HCl, pH 6.8, 62.5% Glycerol, 0.025% BPB, and DTT to a final 
concentration of 125mM. 
10X SDS electrophoresis buffer: 250mM Tris, 10% SDS and 1.92M glycine, pH 8.3 
SDS Equilibration buffer: 6M Urea, 20% SDS, 1.5M Tris, 50% Glycerol, make up to 100ml 
with distilled water. 
12X Separating Gel Buffer: 1.5M Tris-HCl, pH 8.8 
Sodium hydroxide/Sodium dodecyl sulphate (NaOH/SDS): 0.2M NaOH, 1% SDS 
4X Stacking Gel Buffer: 0.5M Tris-HCl, pH 6.8 
TBS-Tween: 20mM Tris-HCl and 150mM NaCl, pH 7.4 and 0.1 % Tween 20  
(stored at -20
°
C) 
TBS-Tween (containing 5% milk): 5% low fat dried milk powder in TBS-Tween 
10X TBE: 0.9M Tris, 0.89M Boric Acid, 25mM EDTA, pH 8.3. This stock solution was diluted 
10 fold for electrophoresis of agarose. 
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TE-CsCl solution: CsCl was added to 1X TE until completely saturated. 
10X TE: 0.1M Tris-HCl, 0.01M EDTA, pH 7.5 
Transfer Buffer: 25mM Tris, 192mM glycine and 20% methanol (stored at -20°C) 
Urea Extraction Buffer: 9M Urea, 2M Thiourea, 4% CHAPS, one tablet of protease inhibitor. 
The solution was made to 50ml with distilled water. 
 
2.3. Cell culture 
H9c2 cells (Rat cardiomyocyte cell line) were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) media supplemented with 10% Fetal Bovine Serum (FBS) and                                          
10% penicillin-streptomycin. All cell culture reagents were obtained from Invitrogen. 
 
2.3.1. Thawing of cells 
DMEM media (5ml) was placed at 4°C to cool down. The vials of frozen H9c2 cells were 
removed from the -150°C freezer and thawed in a 37°C water-bath. The cells were transferred to 
a 15ml tube which contained the pre-cooled 5ml of DMEM media and centrifuged at 3 000 ×g 
for 3 minutes. The supernatant was decanted and the pellet detached. The cells were then 
resuspended in 5 ml media. The latter was put into a 25cm
2
 tissue culture flask. The flask was 
incubated at 37°C at 5% CO2 until confluency was reached. 
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2.3.2. Trypsinization of cells 
The cells were trypsinized once confluency was reached. The DMEM media in the flask was 
discarded and cells were washed with phosphate buffered saline (PBS). The PBS was discarded 
and cells were trypsinized with the addition of 1Χ trypsin and allowed to trypsinize at 37°C for   
2 – 3 minutes. DMEM media was added to the flask to stop trysinization. The cells were 
collected by centrifugation at 3 000 ×g. 
 
2.3.3. Seeding of cells 
Once confluency was reached the cells were trypsinized and resuspended in 5ml DMEM media. 
Cells were counted with the use of the Countess
™
 automated cell counter (Invitrogen). 
Depending on the plate used cells were seeded at a density of 2.5x10
5 
and 1x10
4 
for 6 and        
96-well plates respectively. Cells were incubated at 37
o
C until ready for testing. 
 
2.3.4. Freezing of cells 
For long term storage the cells were trypsinized and centrifuged. The cell pellet was resuspended 
in DMEM media containing 10% dimethyl sulfoxide (DMSO). The latter was aliquoted into 2ml 
cryo-vials and stored at -150°C. 
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2.4. RNA isolation  
The isolation of RNA was carried out with the use of the NucleoSpin
®
 TriPrep kit from 
Macheret-Nagel. The protocol for the isolation of total RNA was done according to the 
manufacturer’s instructions: 
H9c2 cells were cultured in 25cm
2
 flasks. The DMEM media from the cells was decanted, and 
the cells were washed with PBS. Trypsin (1X) was added to the flask and incubated at 37°C   for 
2 minutes. Cells were then viewed under the microscope to confirm detachment from the flasks. 
Once detached, DMEM media was added to the flask and the contents were transferred to a 15ml 
sterile centrifuge tube. The mixture was centrifuged at 3 000 ×g for 3 minutes at 4°C. The 
supernatant was discarded and the cells were washed with PBS to remove traces of the             
1X trypsin. 
The cells were lysed by the addition of Buffer RP1 (350µl) and 1M DTT (7µl). The cells were 
vortexed vigorously for 1 minute in this buffer. The cell suspension was filtered through a 
NucleoSpin
® 
Filter (violet ring) and centrifuged for 1 minute at 11 000 ×g at 25°C. The 
NucleoSpin
®
 Filter was discarded and 70% ethanol (350µl) was added to the lysate. For each 
preparation, a NucleoSpin
®
 TriPrep Column (blue ring) was placed in a collection tube and the 
lysates were loaded onto the column. The samples were centrifuge for 30 seconds at 11 000 ×g. 
Once centrifugation was completed, the NucleoSpin
® 
TriPrep Column was transferred into a new 
collection tube.  
For the extraction of RNA, rDNase reaction mixture was firstly prepared by the addition of 
reconstituted rDNase (10µl) and reaction buffer for rDNase (90µl) in a 0.2ml PCR tube.  
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From this reaction mixture, a volume of 95µl was added directly to the membrane and incubated 
at room temperature for 15 minutes. Buffer RA2 (200µl) was added to the NucleoSpin
®
 TriPrep 
Column and centrifuged for 30 seconds at 11 000 ×g. Once completed, the NucleoSpin
®
 TriPrep 
Column was placed in a new Collection Tube. 
Buffer RA3 (600µl) was added to the NucleoSpin
® 
TriPrep Column and centrifuged for            
30 seconds at 11 000 ×g. The flow-through was discarded and placed in a new collection tube. 
Buffer RA3 (250µl) was added to the NucleoSpin
®
 TriPrep Column and centrifuged for              
2 minutes at 11 000 ×g.  
 
The NucleoSpin
®
 TriPrep Column was placed into a sterile 1.5ml centrifuge tube, RNase-free 
water (50µl) was added to the column and centrifuged for 1 minute at 11 000 ×g. At this point 
the flow-through contained the RNA. The RNA samples were quantified with the use of the 
NanoDrop ND-100 Spectrophotometer (NanoDrop Technologies). 
 
2.5. Agarose gel electrophoresis of RNA 
The isolated RNA was electrophoresed on 1% agarose gels which contained 0.5µg/ml Ethidium 
Bromide. The RNA was diluted with 6X loading buffer and heated at 95°C for 2 minutes. The 
isolated RNA (3.5µg) was electrophoresed on 1% agarose gel, to confirm the integrity of the 
RNA.   
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2.6. Synthesis of cDNA 
 
The first strand cDNA synthesis kit from Roche was used according to the manufacturer’s 
instructions: 
 
An amount of 0.5µg of the isolated RNA was placed in a 1.5ml centrifuge tube. To following 
was added to the 1.5ml microcentrifuge tube: 
Table 2.1 Reagents utilized in the cDNA synthesis reaction  
Reagent Final Concentration 
10X Reaction buffer 1X 
25mM MgCl2 5mM 
Deoxynucleotide Mix 1mM 
Oligo-p(dT)15 Primer 1.6µg 
RNase Inhibitor 50 Units 
AMV Reverse Transcriptase 20 Units 
Sterile Water Variable 
RNA sample Variable 
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For the denaturation of secondary structures the RNA sample was placed on a 65°C heating 
block for 15 minutes and subsequently placed on ice for 5 minutes. RNA was added to the 
reaction mixture followed by brief centrifugation for 3 seconds at 13 200 ×g. The reaction 
mixture was then incubated at 25°C for 10 minutes, followed by 42°C incubation for 1 hour. 
Once the incubation period was completed the reaction mixture was placed at 99°C for 5 minutes 
and placed at 4°C for a period of 5 minutes. The cDNA was quantified with the use of the 
NanoDrop ND-100 Spectrophotometer (NanoDrop Technologies). 
 
2.7. Polymerase Chain Reaction (PCR) of DNA 
PCR reactions were carried out in 10Χ Pfu reaction buffer according to the manufacturer’s 
instructions. The Pfu DNA polymerase (Fermentas) enzyme was used at 2.5U/µl. PCR reactions 
was prepared according to Table 2.2 with the use of gene specific primers (Table 2.3). The 
parameters for the PCR reactions were according to Table 2.4. The annealing temperatures 
(Table 2.5) varied depending on the primer set used.  The agarose gel was viewed using the UVP 
system and the remainder of the sample was electrophoresed on a separate gel. The second gel 
was viewed using the UV- transilluminator and the band was cut out with a sterile blade and 
placed into 1.5ml centrifuge tubes.  The latter was put at - 20°C. 
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Table 2.2 Reagents utilized in PCR reaction 
Reagent Final concentration 
10X Pfu Buffer with MgSO
4
 1X 
Forward Primer 10µM 
Reverse Primer 10µM 
DNA 1µg/µl 
Pfu DNA Taq Polymerase 2.5U/µl 
 
2.7.1 Primers used 
PCR primers were purchased from Inqaba Biotech. 
Table 2.3 Primers used in PCR reactions  
 Primer                                      Sequence 
Forward RhoE                           5’- CACCGATATGAAGGAGAGAAGAGCCAG- 3’ 
Reverse RhoE                           5’- TCACATCACAGTGCAGCTCT -3’  
Forward TIP41                         5’- CACCGATATGATGATCCACGGCTTTCAG- 3’ 
Reverse TIP41                         5’- TTATTCTGAGGGCGCACTTTC- 3’ 
Forward Hsp27                       5’ - CACCGATATGACCGAGCGCCGCGTG - 3’ 
Reverse Hsp27                        5’ - CTACTTGGCTCCAGACTGTTC - 3’ 
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Table 2.4.  PCR Parameters at 35 cycles 
 
 
 
 
 
 
 
 
 
Steps 2 – 4 were repeated 35 times. 
Annealing temperature varied depending on the primer set that was used. Table 2.5 indicates the annealing 
temperature for the primer sets. 
 
Table 2.5.  Annealing Temperature 
 
Gene Annealing Temperature 
RhoE 60°C 
TIP41 60°C 
Hsp27 62°C 
 
 
 
 
 
Parameter Temperature Time 
1. Initial Denaturation 95°C 5 minutes 
2. Denaturation 94°C 30 seconds 
3. Annealing X 30 seconds 
4. Elongation 72°C 1 minute 
5. Final Elongation 72°C 10 minutes 
6. Incubation 4°C ∞ 
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2.8. Agarose gel electrophoresis of DNA 
DNA was electrophoresed on a 1% agarose gel. The agarose was made by boiling the 
appropriate amount of agarose in 1X TBE until dissolved, followed by the cooling of the agarose 
and the addition of ethidium bromide to a final concentration of 1μg/ml. The agarose was poured 
into gel casting trays and allowed to solidify. DNA was mixed with an appropriate amount of gel 
loading buffer before loading the DNA into the wells. The gels were electrophoresed at 100V in 
1X TBE electrophoresis buffer. After electrophoresis, the gels were viewed with the use of UV 
trans-illuminator. Gel images were captured with an image capture system (Kodak Digital 
Science ID). 
 
2.9. Gel purification of DNA 
The DNA was electrophoresed on a 1% agarose gel in 1X TBE (Section 2.8). The DNA was 
viewed with the use of long wavelength (360nm) UV lamp. The DNA fragment of interest was 
cut out with a sterile blade. The PureLink
™
 Quick Gel Extraction Kit from Invitrogen was used 
according to the manufacturer’s instructions. The gel slice which contained the DNA fragment 
was weighed in a 5ml tube. To the latter, 6 volumes of Gel Solublilzation Buffer (L3) for every 
400mg of gel was added. The tubes were placed in a 50°C heating block for 10 minutes. The 
tubes were inverted every 3 minutes to ensure gel dissolution. The gel slice was incubated for a 
further 5 minutes. The solution containing the DNA fragment of interest was pipetted onto a 
PureLink
™
 Clean-up Column tube.  
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The column was inserted into a 2ml centrifuge tube and centrifuged at 10 000 ×g for 1 minute. 
The flow-through was discarded and 700µl of wash buffer was added to the PureLink
™
 Spin 
Column. The column was centrifuged at 16 000 ×g for 2 – 3 minutes to remove any residual 
wash buffer and ethanol. The PureLink
™
 Spin Column was placed onto a sterile 1.5ml centrifuge 
tube. An amount of 50µl Elution buffer was added to the centre of the PureLink
™
 Spin Column. 
The column was incubated for 1 minute at room temperature. The column was centrifuged at      
10 000 ×g for 1 minute to elute purified DNA. The purified DNA was stored at –20°C.    
 
2.10. DNA Cloning 
2.10.1. Cloning vector 
The expression system pcDNA™ 3.1D/V5-His-TOPO® was purchased from Invitrogen (Figure 
2.1). It is a 5.5kb mammalian expression vector designed to facilitate rapid cloning of          
blunt-ended PCR products for expression in mammalian cells. The vector allows for high level 
expression, detection and purification of heterologous proteins in most mammalian cells. The 
vector contains the following features: a human cytomegalovirus (CMV) immediate early 
promoter which allows high level constitutive expression of the gene of interest, a TOPO
®
 
Cloning Site for rapid and efficient directional cloning of blunt-ended PCR products, and a 
Neomycin resistance gene for the selection of stable transfectants in mammalian cells. The 
vector has two epitopes the V5-epitope and the C-terminal polyhistidine tag which can be used in 
the detection of the recombinant protein of interest with the use of the Anti-V5 and Anti-His     
C-terminal antibodies, respectively.  
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For the sequencing of constructs it has a T7-promoter priming site which enables sequencing 
through the insert. The BGH reverse priming site allows for the sequencing through the insert in 
reverse orientation. 
Figure 2.1: A circular map of pcDNA
™
3.1D/V5-His-TOPO
®
 vector system. 
 
2.10.2. Ligation of PCR products 
The pcDNA™ 3.1 Directional TOPO® Expression Kit was used to clone PCR products in the 
vector pcDNA™ 3.1D/V5-His-TOPO according to the manufacturers instructions: 
The 3 inserts (RhoE, TIP41 and Hsp27) were purified and quantified on the NanoDrop ND-100 
Spectrophotometer from NanoDrop Technologies. 
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The amount of insert used in the ligation reactions were calculated using the following equation: 
    ng of vector X kb size of insert                               insert:vector ratio 
        kb size of vector  
 
Table 2.6.  Reagents utilized in the ligation reactions of RhoE, TIP41, Hsp27 into the 
pcDNA™ 3.1D/V5-His-TOPO vector. 
Vector:Insert Ratio 3:1 
PCR product (9 ng/µl) 2µl 
Salt Solution 1µl 
Sterile Water 2µl 
Vector (pcDNA
™
 3.1D/V5-His-TOPO) 1µl 
Total 6µl 
 
2.10.3 Transformation of ligation reactions 
The reaction mixture was gently mixed and incubated for 5 minutes at room temperature. A 
fraction of the ligation (2µl) was added to a vial of One Shot
®
 TOPO10 chemically competent E. 
coli cells and gently mixed. The latter was incubated on ice for 30 minutes and heat-shocked for 
30 seconds at 42°C and immediately transferred into an ice-bath.  
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SOC medium (250µl) was added to the reaction mixture and incubated at 37°C for 1 hour with 
shaking. Thereafter an amount of 75µl of bacterial culture was plated on pre-warmed agar plate 
(containing 100µg/ml ampicillin) and incubated overnight at 37°C.  
 
2.10.4. Colony PCR 
Following transformation the colonies were screened for the presence of the insert (RhoE, TIP41 
and Hsp27) with the use of colony PCR. Random colonies were selected from the plate and 
resuspended in 5µl of sterile H2O. The parameters for the PCR reactions were the same as 
previously mentioned in Section 2.7. The resuspended colony (1µl) was used as a template in the 
PCR. Colony PCR was carried out using 2Χ Dream Taq™ Green buffer according to the 
manufacturer’s instructions. Positive clones (two clones for each gene) were sent to Inqaba 
Biotec for sequencing analysis. 
 
2.11. Purification of pcDNA-RhoE, pcDNA-TIP41 and pcDNA-Hsp27 on Cesium   
      chloride/Ethidium bromide  gradients. 
Positive clones were inoculated in 500ml luria broth (LB) which contained 100µg/ml ampicillin. 
Cultures were incubated at 37°C overnight. Bacteria was pelleted by centrifugation at 4 500 ×g 
for 10 minutes at 4ºC. The pellet was resuspended in GTE buffer and incubated on ice for         
10 minutes. The cells were lysed by addition of NaOH/SDS. The cells were incubated in 
NaOH/SDS on ice for 10 min. Potassium acetate (3M solution) was added and mixed gently to 
neutralise the NaOH/SDS, and the mixture was incubated on ice for 10 minutes. The precipitate 
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of cell debris and, chromosomal DNA was removed by centrifugation at 4 500 ×g for 15 minutes 
at 4ºC. The supernatant was filtered through a glass wool to remove particulate material and 
nucleic acids were precipitated by the addition of 0.8 volumes propan-2-ol, followed by 
incubation at -20ºC for 20 min. The precipitate was pelleted by centrifugation at 10 000 ×g for 
10 minutes at 4ºC. Plasmid DNA was separated from RNA by double CsCl/ethidium bromide 
fractionation. 
The pellet was resuspended in 1X TE. The solution was mixed with 4mg/500µl ethidium 
bromide, and CsCl (5.75g)  to give a final density of 1.61g/ml (cell density was determined by 
weighing the sample). The mixture was then centrifuged at 10 000 ×g for 10 minutes at 4ºC. The 
TE/CsCl (5ml) to give a final density of 1.61g/ml. The samples were transferred to Quickseal 
tubes (Beckman Coulter) and centrifuged at 55 000 ×g for 18 hours at 20ºC in the Optima
™
 L-80 
ultracentrifuge (Beckman Coulter) using a NVi 65 rotor. The plasmid DNA in Quick seal tube 
was visualised under a 360nm UV illumination. The band representing the plasmid DNA was 
recovered using a syringe. An equal volume of NaCl-saturated isopropanol was added to the 
sample and centrifuged for 10 minutes at 10 000 ×g. Centrifugation generated two fractions. The 
top fraction was removed.  This extraction with NaCl-saturated isopropanol was repeated four 
times. Two volumes of water and one volume of isopropanol were added to precipitate the DNA. 
This mixture was mixed well and incubated on ice for 10 minutes. The DNA was recovered by 
centrifugation at 10 000 ×g for 15 min. The pellet was resuspended in 1X TE and stored at          
-20ºC.  
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2.12. Transfection of pcDNA-RhoE, pcDNA-TIP41 and pcDNA-Hsp27 into H9c2 cells 
H9c2 cells were cultured in 25cm
2
 flasks until 70 – 90 % confluency was reached. The DMEM 
media was decanted and the cells were washed with 1X PBS. The PBS was decanted and 1X 
trypsin was added to the cells and incubated at 37°C for 3 minutes. DMEM media was added and 
the cells were transferred into a 15ml tube and centrifuged at 3 000 ×g for 3 minutes. The 
supernatant was decanted and the pellet resuspended in media. The cells were then seeded into 6 
well plates as described in Section 2.3.3 and incubated until 70 % confluent.  
Transfections were carried out with the use of Metafectene
®
 Pro Transfection Reagent (Biontex) 
according to the manufacturer’s instructions.  
The following solutions were prepared, Solution A consisted of the plasmid DNA (2µg), which 
was added in 50µl of DMEM serum free media and Solution B consisted of 6 µl of Metafectene
®
 
Pro Transfection Reagent in 44µl of DMEM serum free media. Solution A was added to solution 
B and incubated at room temperature for 20 minutes. The media was removed from the cells in 
the 6-well plates and the cells were washed with 1X PBS. The PBS was removed and 500µl of 
DMEM serum free media was added to each well. The DNA-Metafectene mixture was added 
drop-wise to the appropriate well and the plate was gently swirled. The cells were incubated for 
3 hours. Thereafter 1ml of complete DMEM media was added to each well. After 24 hours the 
media was replaced with complete DMEM media which contained 800µg/ml of G418 
(Invitrogen). The media was changed every 48 hours until all the cells in the control well were 
dead. The selective media was replaced with complete DMEM media after 10 days and the 
transfectants were allowed to grow. Once the wells were confluent, the cells were trypsinized 
and each well was sub-cultured into a 25cm
2
 flask until confluency was reached. 
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2.13. Analysis of the cell viability  
Cells were cultured until confluency was reached. The cells were trypsinized and seeded into   
96-well plates and incubated at 37°C until confluency was reached. Two of the H9c2 96-well 
plates were subjected to 1 hour of heat shock pretreatment at 42°C and allowed to recover for 2 
and 4 hours at 37°C. The cells were treated with 250µM or 500µM ceramide and camptothecin 
and incubated at 37°C for 24 hours at 37°C. Cell viability was assessed using the MTT Assay 
according to the manufacturer’s instructions: The MTT powder (5mg/ml) was prepared in PBS 
and filtered through a Millipore filter. Five hours prior to the end of the 24 hour incubation 
period, 10µl of the MTT dye was added to each well. After the 24 hour period the media was 
discarded. The cells and MTT were solubilized with the addition of DMSO to each well. The 
plates were rocked for 5 – 10 minutes and read with the use of the platereader at 560nm. 
 
2.14. Analysis of the cell viability of heat shock preconditioned H9c2 cells. 
H9c2 cells were cultured in 96-well cell culture plates as described in Section 2.14. The cells 
were subjected to heat shock pre-treatment at 42°C for an hour, followed by recovery periods of 
2 and 4 hours at 37°C. Thereafter the cells were treated with 250µM and 500µM of ceramide or 
camptothecin for 24 hours. 
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2.15. Protein Extraction 
Protein extraction was carried out with the use of CytoBuster
™
 Protein Extraction Reagent 
(Novagen) according to the manufactures instructions. Wild type H9c2 cells and transfected 
H9c2 cells (H9c2-RhoE, H9c2-TIP41 and H9c2-Hsp27) were cultured until confluency was 
reached. The media was decanted and the cells were washed with 1X PBS. The recommended 
amount of CytoBuster was added and the cells were placed on a shaker for 5 minutes. Following 
incubation the cells were scraped off in the CytoBuster
™
 reagent and placed into a 1.5ml tube. 
Cells were centrifuged for 5 minutes at 16, 000 ×g at 4°C. The supernatant containing the 
proteins were removed and stored at –20°C. 
 
2.16 1D SDS-Polyacrylamide Gel Electrophoresis 
2.16.1 Gel preparation 
The proteins were separated with the use of the 1D polyacrylamide gel electrophoresis. Glass 
plates and apparatus (Bio-Rad) used were first cleaned to ensure that they were free of 
acrylamide. A 12 % separating solution was prepared according to Table 2.7. To the separating 
solution, 20μl of TEMED was added and the solution was poured between the gel plates. The 
separating gel solution was overlaid with 1ml of isopropanol and allowed to solidify. 
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Table 2.7: Stock solutions for the 12% Separating gel solution 
Reagent Volumes 
Separating Buffer (1.5M 
Tris-HCl, pH8.8) 
2.5ml 
40% Acrylamide-Bis (37:5:1) 3ml 
10% SDS 0.1ml 
10% APS 0.1ml 
Distilled water 4.3ml 
TEMED 0.02ml 
Total volume 10.02ml 
 
The stacking gel solution was prepared according to Table 2.8. Once the separating solution was 
solidified the isopropanol was poured off and the gel was rinsed thoroughly with distilled water. 
TEMED (0.02ml) was added to the stacking solution and was immediately poured in between 
the gel plates and a 10 well Bio-Rad comb was inserted onto the stacking gel immediately, the 
gel was allowed to solidify for 10 to 15 minutes. After the gel solidified, the comb was removed 
and the gel was set up in the gel electrophoresis tank (Bio-Rad). The tank was filled with 1X 
SDS running buffer and was pre-run at 80V for 5 minutes so as to remove any SDS or liquid 
acrylamide from the gel wells. 
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Table 2.8: Stock solutions for the 5% stacking gel solution 
Reagent Volumes 
Stacking Buffer (1M Tris-
HCl, pH6.8) 
0.5ml 
40% Acrylamide-Bis 
(37:5:1) 
0.63ml 
10% SDS 0.05ml 
10% APS 0.05ml 
Distilled water 3.77ml 
TEMED 0.02ml 
Total volume 5.02ml 
 
2.16.2 Sample preparation and gel loading 
The protein samples were removed from -20°C and thawed immediately. In a 1.5ml tube, 50μl of 
the protein sample was added to 10μl of 5X sample buffer. The samples were centrifuged at 
16 000 ×g using benchtop Eppendorf centrifuge for 5 minutes. The protein molecular marker 
was boiled for 5 minutes at 95°C. The samples were loaded onto the polyacrylamide gel and 
were electrophorised at 100V until the Coomassie dye front reached the bottom of the gel. 
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2.16.3 Gel staining 
The gel was removed from the gel plates and stained in Coomassie staining solution for            
45 minutes on a shaker. The staining solution was removed and the gel was destained for 10 to 
16 hours while shaking in destaining solution. 
 
2.17. Analysis of RhoE, TIP41 and Hsp27 expression by Western Blot analysis 
2.17.1 Blot transfer of proteins onto PVDF membrane 
The proteins were electrophoresed with the use of the 1D SDS polyacrylamide gel 
electrophoresis as described in Section 2.16. After electrophoresis the proteins were transferred 
onto the PVDF membrane (BioTrace
™
) by blot transfer. The blot apparatus were set by placing 
the blot cassette, a scouring pad equilibrated in a transfer buffer for few minutes, two filter 
papers equilibrated in transfer buffer and then placing the gel, on the negative side of the 
cassette. The PVDF membrane was placed in methanol for few seconds was placed onto the gel 
followed by two filter papers and the scouring pad. The blot apparatus was set in the running 
tank filled with ice cold transfer buffer and the proteins were electroblotted for 90 minutes at 
110V. The temperature was kept at 2 - 8°C. After blot transfer the membrane was either used 
immediately or stored between 2 sheets of filter paper at 4°C until further use. 
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2.17.2 Analysis of RhoE, TIP41 and Hsp27  
The membrane was blocked in TBS-Tween (containing 5% milk) for 1 hour at room 
temperature. After 1 hour the membrane was washed with TBS-Tween. The membrane was 
incubated in the primary antibody (RhoE 1:500, TIP41, 1:500, Hsp27 1:500 and V5 Probe 1:250) 
overnight at 4°C. The antibody was diluted TBS-Tween (containing 3% BSA). The following 
day the membrane was washed in TBS-Tween (containing 5% milk). This was repeated 3 times 
with shaking at room temperature for 5 minutes 3 times. For RhoE and for the V5 probe, the 
secondary antibody donkey anti-goat (1:2000) was used and mixed with Actin (1:500). For 
TIP41 and Hsp27, the secondary antibodies, donkey anti-goat (1:2000) and goat anti-mouse 
(1:5000) was used respectively. The membrane was incubated for 30 minutes at room 
temperature in the diluted secondary antibody. The membrane was washed with TBSTween 
(containing 5% milk) for 5 minutes at room temperature with shaking. This was repeated            
3 times. The membrane was washed with TBS-Tween for 5 minutes at room temperature with 
shaking. This was repeated 3 times. Then the membrane was incubated with 4ml Super Signal 
West Pico Working solution (Thermo Scientific) for 5 minutes in a dark room. 
 
2.17.3 Development of the film 
A CL-XPosure film (Thermo Scientific) was exposed to the blot for 1 and 5 minutes. After the 
exposure of the film, the films were developed in a Cunx 60 x-ray developer (AFGA).  
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2.18. Two-dimensional Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (2D 
SDS-PAGE).  
The H9c2 and H9c2-RhoE cells were cultured in 25cm
2
 cell culture flasks until confluency was 
reached. Thereafter proteins were extracted from each cell line with the use of CytoBuster
™
 
Protein Extraction Reagent as described in Section 2.15. The proteins were precipitated by the 
addition of ice cold acetone (4X the volume of the sample). The latter was put at –20°C for         
2 – 3 hours with vortexing in between. After the incubation period the samples were centrifuged 
at 13 000 ×g for 10 minutes at 4°C. The supernatant was decanted and the acetone was allowed 
to evaporate for 30 minutes. After 30 minutes the protein pellet was resuspended in 150µl of 9M 
urea buffer.    
              
2.18.1. Reswelling of IPG strips 
The proteins were quantified using the Bradford assay (Bradford, 1976). Thereafter an amount of 
100µg for each protein sample (H9c2 and H9c2-RhoE) was used. The components in preparation 
for reswelling were mixed in a 1.5ml microfuge tube (as indicated in Table 2.9). The samples 
were loaded onto separate channels of Immobiline
TM
 Reswelling Dry-Strip tray (GE Healthcare). 
The strips (7 cm, pH 4-7, ReadyStrip
TM
 Immobilized pH Gradient (IPG) strip,    Bio-Rad) were 
placed on top of the protein samples with the gel side in-contact with the samples, avoiding 
trapping air bubbles. The IPG strips were overlaid with mineral oil (PlusOne DryStrip Cover 
Fluid; GE Healthcare) to prevent evaporation and urea crystallization. The IPG strips were left to 
reswell overnight at room temperature. 
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Table 2.9: Preparation of protein samples for reswelling. 
 
Reagents Tube 1 
Protein sample x µl 
Ampholytes 1.25µl 
50% DTT 
2µl 
Urea Buffer x µl 
Total 125µl 
 
2.18.2 Isoelectric focusing (IEF)  
After reswelling, the IPG strips were removed from the Immobiline
TM
 Dry Strip Reswelling tray 
(GE Healthcare) using forceps and rinsed with distilled water. The IPG strips were lightly blotted 
on the filter paper to remove excess moisture and placed gel side up on the IEF tray 
(Ettan
TM
IPGphor II
TM
, GE Healthcare) for the first-dimension separation. Filter paper wicks 
were blotted on a paper towel with distilled water and placed on the ends of the strips to absorb 
excess salts and other impurities during the IEF electrophoresis. The IPG strips were overlaid 
with oil to avoid drying of strips. The IEF conditions (Table 2.10) were set up and the machine 
was run at 20°C. 
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Table 2.10: Isoelectric focusing conditions for 7cm IPG strips. 
 
 Volts Time 
Step 1 250 0:15 hr 
Step 2 4000 1:00 hr 
Step 3 4000 12 000V/hr 
 
2.18.3. Equilibration of strips 
After the IEF run, the strips were removed from the IEF machine and rinsed with distilled water 
to remove excess urea and the mineral oil. The IPG strips were placed on an equilibration tray, 
gel side up and 2ml of DTT equilibration buffer was added. The solution was left to gently shake 
on an orbital shaker for 20 minutes. The DTT was discarded and 2ml of iodocetamide 
equilibration buffer was added and left to shake for another 20 minutes. The iodocetamide 
equilibration buffer was discarded and the IPG strips were ready to be loaded onto 2D PAGE 
gels. 
 
2.18.4. Separation of proteins in the second dimension 
The 12% SDS-PAGE resolving gels were prepared as described in Section 2.16.1. However 
without the stacking gel (Table 2.7). The gel casting plates were assembled during the IEF run. 
The gels were poured into the casting plates, overlaid with isopropanol and left to polymerise. 
After the equilibration step, the absolute isopropanol was poured off and gel surfaces were rinsed 
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with distilled water. The IPG strips were rinsed in 1X SDS running buffer. The protein marker 
(PageRuler
TM
 unstained protein ladder, Fermentas) was blotted on a piece of filter paper and 
allowed to air dry. The IPG strips and the protein markers were placed onto the separating gels 
and overlaid with the agarose sealing solution. The gels were electrophoresed at 100V until the 
bromophenol blue entered the resolving gel. The voltage was increased to 120V until the 
bromophenol blue reached the bottom of the gel. The gels were removed from the apparatus and 
placed in a plastic container, stained with CBB and destained with destaining solution (10% v/v 
acetic acid and 1% v/v glycerol) until excess dye was removed from the background gel matrix. 
After destaining, the gels were stored in distilled water, imaged with PDQuest
TM
 Basic software 
version 8.0. 
 
2.19. PDQuest
TM
 Basic software image analysis 
 
2.19.1 Gel image analysis 
 
Gels were scanned using a PharosFX
TM
 Plus Molecular Imager scanner (Bio-Rad). The scanned 
gels were analysed using the PDQuest
TM
 Basic software version 8.0 (Bio-Rad). The gels were 
grouped as control (3X H9c2) and experimental (3X H9c2-RhoE) biological replicate groups and 
also a master gel was automatically created for all the gels. Group consensus was used to 
automatically match the spots in the replicate gels of both groups to the master gel, followed by 
manual editing of the spots. Once the spots were correctly matched, the spot viewer was used to 
identify the differentially expressed spots between the control and experimental replicate groups 
using the analysis set (either quantitative or T-test). The quantitative test was used with an upper 
limit of 1.5 and lower limit of 0.5 fold difference and a T-test with the significance level of 95% 
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(Dubey and Grover, 2001). The spots of interest were selected, labelled on a gel and 
automatically excised into 96 well plate using ExQuest
TM
 Spot Cutter (Bio-Rad). 
 
2.20. Spot cutting and trypsinization 
Differentially expressed protein spots which showed variation in expression were excised using 
the Bio-Rad XQuest Spot cutter which automatically transferred the spots to individual wells of a 
96 well plate. Individual gel plaques were transferred to labelled sterile microcentrifuge tubes 
and were initially washed twice with 650μl of 50mM ammonium bicarbonate, briefly vortexed 
and left for a period of 5 minutes. Following the two washes of 5 minutes, each the solution was 
carefully removed. A third wash using the same reagent and volume was carried out with 
occasional vortexing during a 30 minute period. Thereafter the solution was again carefully 
removed. The gel plaques were destained twice with 650μl of a 50% (v/v) 50mM ammonium 
bicarbonate and 25% (v/v) acetonitrile solution for a period of 30 minutes each with occasional 
vortexing. The destained gel pieces were dehydrated with 100 μl of 100% (v/v) acetonitrile for a 
period of five minutes and completely dried using a Speed Vac SC100 (Savant). Proteins were 
in-gel digested with porcin trypsin solution (Promega) buffered in 25 mM ammonium 
bicarbonate. A volume of 10μl of 10μg/ml trypsin was added to the dried gel piece. The gel 
plaques were placed at 37°C overnight. 
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2.21. Mass spectrometry (MS) for protein identification 
Mass spectrometry analysis of protein spots were conducted by Mrs Roya Minnis-Nbimba 
(Proteomics Laboratory, UWC) as previously described (Thomas et al., 2010). A volume of 1μl 
of digested proteins were mixed separately with an equivalent volume of α-cynahydroxy-
cinnamic (CHCA) matrix and spotted onto a target plate for analysis by matrix assisted laser 
desorption/ionisation-time of flight (MALDI-TOF) MS using a Voyager DE Pro 
Biospectrometry workstation (Applied Biosystems) which generated peptide mass fingerprints 
(PMF). The positive ion delayed extraction reflector mode was employed by MALDI-TOF MS 
which provided the highest resolution and mass precision. A 337nm laser was used to ionize 
peptides and spectra were attained at 20kV acceleration potential with optimized parameters. 
Close external calibration was employed using the Sequazyme calibrationTM mixture II 
containing angiotensin I, adrenocorticotropic hormone (ACTH; 1-17 clip), ACTH (18-39 clip) 
and bovine insulin (applied biosystems). This calibration method typically provided mass 
accuracy of 150ppm across the mass range of 40 850 to 4,000Da. Peptide spectra of accumulated 
1,000 shots each were automatically processed for baseline correction, noise removal and peak 
de-isotoping. Threshold was manually adjusted between 2% and 8% base peak intensity. All 
searches were performed against the National Centre for Biotechnology Information non-
redundant (NCBInr) database using the MASCOT algorithm 
(<http://www.matrixscience.com/search_form_select.html). The searches were performed using 
a peptide mass tolerance of 150ppm, allowing one maximum missed cleavage and oxidation of 
methionine as an amino acid modification. Candidate identifications with molecular weight 
search (MOWSE) scores of greater than 72 were considered significant and therefore denoted as 
positive protein identifications. If more than one protein satisfied MOWSE scores of greater then 
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72, the hit with the highest MOWSE score was assigned. Search criteria required a minimum of 
four matches of the matched peptides for validation (Thomas et al., 2010). 
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CHAPTER 3:  
RESULTS 
3.1 Evaluating the expression levels of RhoE, TIP41 and Hsp27 in response to heat shock 
3.1.1 Introduction 
Heat shock preconditioning is a phenomenon in which cells are subjected to elevated 
temperature which is approximately 3 - 5°C above basal level (Lindquist, 1986). The latter leads 
to the induction of heat shock responsive proteins such Hsp27. Hsps, also referred to as stress 
proteins enables protection against subsequent injury. Studies have shown that cardiomyocytes 
which are subjected to heat shock pre-treatment lead to enhanced resistance to apoptosis (Currie 
et al., 1998; Yellon et al., 1992). Numerous studies have indicated that heat shock 
preconditioning lead to the inhibition of cysteine aspartic proteases (caspases) as a result of the 
induction of Hsps (Iliodromitis et al., 2007). A previous study using suppression subtractive 
hybridization demonstrated that the expression of RhoE and TIP41 is induced in response to heat 
shock in H9c2 cells (Gill, 2004).  
 
The aim of this section was to evaluate the expression of RhoE, TIP41 and Hsp27 in response to 
heat shock. Heat shock preconditioning is an in vitro experimental method in which H9c2 cells 
are subjected to 42°C for an hour.  
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3.1.2. Western blot analysis of RhoE, TIP41 and Hsp27 expression in heat shocked H9c2  
          cells. 
The first step was to culture H9c2 cells in 25cm
2
 tissue culture flasks until confluency was 
reached. Thereafter the H9c2 cells  were preconditioned  by heat shocking the cells for an hour at 
42°C, followed by recovery periods of 0, 6, 12 and 24 hours at 37°C. Proteins were extracted 
with the use of CytoBuster Extraction Reagent (Section 2.15) and used to evaluate the expression 
of RhoE, TIP41 and Hsp27 by Western blot analysis with antibodies specifically for RhoE, 
TIP41 and Hsp27.   
 
 
 
 
  
 
 
 
 
 
 
Figure 3.1: The expression of RhoE, TIP41 and Hsp27 in H9c2 cells in response to heat shock pretreatment. The 
expression of TIP41 and RhoE is present in unstressed cells and the expression of Hsp27 is absent in unstressed 
cells. The expression of Heat shock protein 27 is present at 1 and 6 hours only. TIP41 and RhoE expression are 
present at 1, 6 12 and 24 hours following heat shock pre-treatment. The Western blot was repeated 3 times. 
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The result in Figure 3.1 confirms that RhoE, TIP41 and Hsp27 expression is induced in response 
to heat shock pre-treatment. At time points 12 and 24 hours the expression of Hsp27 is absent, 
whereas the expression of TIP41 and RhoE is present in unstressed cells and at 1,6,12, and 24 
hours. 
 
3.2. Cloning of RhoE, TIP41 and Hsp27 into pcDNA
™
 3.1 D/V5-His-TOPO vector system. 
3.2.1. Introduction 
It was demonstrated in Section 3.1.2 that RhoE, TIP41 and Hsp27 are induced by heat shock. 
The next objective was to over-express these proteins in H9c2 cells and to assess whether     
over-expression of these proteins protects these cells against cell death. To achieve this genes 
encoding RhoE, TIP41 and Hsp27 was cloned into the pcDNA
™
3.1D/V5-His-TOPO vector 
system.  
 
3.2.2. The isolation of RNA from H9c2 cells 
H9c2 cells were cultured in 25cm
2
 tissue culture flasks at 5% CO2 at 37°C until confluency was 
reached as described in Section 2.3. Total RNA was isolated with the use of the NulceoSpin
®
 
TriPrep kit as described in Section 2.4. The RNA was electrophoresed on an agarose gel (Figure 
3.2). The RNA in Figure 3.2 indicates the two RNA subunits (28S and 18S). Figure 3.2 indicates 
slight smearing of the RNA samples, however the RNA subunits (28S and 18S) are intact which 
suggests that the RNA was of sufficient quality.  
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Figure 3.2: Total RNA isolated from H9c2 cells with the use of the NucleoSpin
®
 TriPrep kit. The first lane indicates 
the DNA ladder, the second lane indicates total RNA. The two arrows on the left shows the molecular weights 
(2.5kb and 2kb) of the two subunits indicated by the red arrows (28S and 18S) present in the total RNA sample. 
 
3.2.3. PCR amplification of RhoE, TIP41 and Hsp27. 
cDNA was synthesized from the isolated total RNA with the use of the first strand cDNA 
synthesis kit for RT-PCR (AMV) from Roche  as described in Section 2.6. Gene specific primers 
were designed for the amplification of RhoE, TIP41 and Hsp27 which were synthesized by 
Inqaba Biotech (See Table 2.3). The cDNA was used as a template to PCR amplify the coding 
region of RhoE, TIP41 and Hsp27 with the use of gene specific primers. PCR amplification of 
RhoE, TIP41 and Hsp27 was performed as described in Section 2.7. Figures 3.3 A, B and C 
indicate the amplified PCR products which were electrophoresed on a 1% agarose gel.  
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Gel images were captured with the image capture system (Kodak Digital Science ID). The PCR 
amplification in Figure 3.3 indicates a PCR product for each gene (RhoE, TIP41 and Hsp27) at 
approximately the expected size for the individual genes. Each PCR product was cut out and 
purified as described in Section 2.9. The purified product was ligated into the                           
pcDNA
™
 3.1 D/V5-His-TOPO vector. 
. 
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Figure 3.3: PCR amplification of RhoE, TIP41 and Hsp27 with the use of gene specific primers. Figure A shows, the amplified PCR product for RhoE                  
at expected size of ~735bp, Figure B shows, the amplified PCR product for TIP41 at the expected size of ~816bp and Figure C shows, the amplified                        
PCR product for Hsp27 at the expected size of ~618bp. The first lane in each gel shows the DNA marker, the second lane shows the negative control and               
the third lane shows the amplified PCR product for each gene.
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3.2.4. Ligating RhoE, TIP41 and Hsp27 into pcDNA
™ 
3.1 D/V5-His-TOPO vector. 
The amplified PCR products were cut out of the gel with the use of a sterile blade as described in 
Section 2.7. The PCR products were purified with the use of the PureLink™ Quick Gel 
Extraction Kit as described in Section 2.9. The purified DNA was used in a ligation experiment 
in order to ligate each PCR product into the vector pcDNA
™
 3.1D/V5-His-TOPO vector. The 
ratio (insert:vector) used for each reaction was 3:1 as described in Table 2.6 and the ligation 
reaction was used to transform E.coli competent cells as described in Section 2.10.3.  
   
3.2.5. Colony PCR screening for RhoE, TIP41 and Hsp27 positive clones. 
Colonies were randomly picked from the transformation plates for RhoE, TIP41 and Hsp27 and 
resuspended in sterile water. These colonies were screened by PCR amplification with the use of 
gene specific primers for the presence of the inserts. The PCR products were electrophoresed on 
a 1% agarose gel and images were captured with the image capture system (Kodak Digital 
Science ID). Figure 3.4: Indicates the amplified PCR products from colony PCR screening for 
RhoE, TIP41 and Hsp27. The products which were amplified for each gene were the expected 
size for the respective genes.  
 
 
 
 
65 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Screening for positive RhoE, TIP41 and Hsp27 clones by colony PCR with the use of gene specific primers. A- shows clones for RhoE at the 
expected size ~735bp, B- shows clones for TIP41 at the expected size ~816bp and C- shows clones for Hsp27 at the expected size ~618bp. The second lane 
shows the negative control in which water was used as a template in the PCR reaction. 
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3.2.6. Sequence analysis of RhoE, TIP41 and Hsp27 constructs. 
Positive clones for all three genes were cultured in LB-ampicillin and streaked onto                
LB-ampicillin agar plates as described in Section 2.11.1. Agar plates containing positive clones 
for RhoE, TIP41 and Hsp27 were sent to Inqaba Biotec for sequencing. Two clones for each 
gene was chosen and sequenced in the forward and reverse orientation with the use of T7 and 
BGH sequencing primers. The DNA sequences received from Inqaba Biotec were translated into 
protein sequence with the use of ExPASy translation tool. The translated protein sequences were 
aligned with the expected protein sequence for these genes in the NCBI database. The protein 
identifications (ID) for the expected protein sequences were NP_001007642, NP_001103137 and 
NP_114176, for RhoE, TIP41 and Hsp27 respectively. Figure 3.5 indicates the pairwise 
sequence alignment of the translated DNA sequence of RhoE, TIP41 and Hsp27. Clones for 
RhoE and TIP41 were 100% identical, whereas the clone for Hsp27 was 99 % identical.  
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Figure 3.5: Pairwise protein sequence alignment of translated DNA sequence for positive clones (A) shows RhoE, 
(B) TIP41 and (C) Hsp27. The translated DNA sequences were compared with the protein sequence of Rattus 
norvegicus RhoE, TIP41 and Hsp27. RhoE (A) and TIP41 (B) shows no mutations in the protein sequence, whereas 
Hsp27 (C) has 2 mutations indicated by the red boxes. 
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3.3. The generation of H9c2 cells that stably over-express RhoE, TIP41 and Hsp27. 
 
3.3.1. Introduction 
The objective of this section was to create three mutant H9c2 cell lines which stably              
over-express RhoE, TIP41 and Hsp27. The over-expression of these proteins in these cells can be 
confirmed by Western blot analysis.  
 
3.3.2. Plasmid isolation of RhoE, TIP41 and Hsp27 constructs. 
The first step was to make large cultures of pcDNA 3.1-RhoE, pcDNA 3.1-TIP41 and        
pcDNA 3.1-Hsp27. The plasmids were isolated with the use of Cesium chloride/Ethidium 
bromide gradient as described in Section 2.11.  
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Figure 3.6: Plasmid isolation of pcDNA 3.1-RhoE, pcDNA 3.1-TIP41 and pcDNA 3.1-Hsp27 with the use of 
Cesium chloride/Ethidium bromide gradient. Figure 3.6 shows isolated plasmid DNA (pcDNA 3.1-RhoE, pcDNA 
3.1-TIP41 and pcDNA 3.1-Hsp27) all of high molecular weight with distinct band separation. 
 
The plasmid DNA in Figure 3.6 is of high molecular weight and is of sufficient quality to 
continue to the next step which is to transfect these constructs into H9c2 cells. 
 
3.3.3. Generation of mutant cell lines, H9c2-RhoE, H9c2-TIP41 and H9c2-Hsp27. 
H9c2 cells were seeded into 6-well plates and cultured until 70% confluent. Each of the three 
constructs were transfected into H9c2 cells with the use of Metafectene
®
 Pro Transfection 
Reagent from Biontex as described in Section 2.12. H9c2 cells were transfected with 2µg of 
pcDNA 3.1-RhoE, pcDNA 3.1-TIP41 and pcDNA 3.1-Hsp27, respectively. After 24 hours, the 
cells were treated with 800µg/ml of G418 until all the cells in the control (Untransfected cells) 
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were dead. Thereafter the selective media was removed and replaced with complete DMEM 
media.  
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Photograph of H9c2 cells following transfection of (b) pcDNA 3.1-RhoE,(c) pcDNA 3.1-TIP41 and  (d)  
pcDNA3.1-Hsp27 into H9c2 cells with the use of  Metafectene
®
 Pro Transfection Reagent. Figure (a) shows the 
untransfected cells which are in the process of cell death as indicated by the red arrows and (b), (c) and (d) shows 
cell survival of H9c2 cells transfected with pcDNA 3.1-RhoE (b), pcDNA 3.1-TIP41 (c) and pcDNA 3.1-Hsp27 (d). 
The result in Figure 3.7 shows that RhoE, TIP41 and Hsp27 are resistant to G418. This may 
suggest that the cells are transfected with the plasmid and that the cells are also over-expressing 
the proteins. The latter needs to be confirmed by Western blot analysis. 
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3.3.4. Confirming the over-expression of transfected cells by Western blot analysis. 
The three mutant cell lines, H9c2-RhoE, H9c2-TIP41 and H9c2-27 and wild type H9c2 cells 
were cultured until confluency was reached. Thereafter proteins were extracted from each cell 
line with the use of CytoBuster
™
 Protein Extraction Reagent (Novagen) as described in Section 
2.15. The vector (pcDNA™ 3.1D/V5-His-TOPO®) has a C-terminal peptide containing the    
V5-epitope which is used in the detection of recombinant protein of interest. These proteins were 
analysed to confirm the presence of the transfected constructs with the use of an Anti-V5 probe 
(Santa cruz). 
 
 
 
 
 
 
 
Figure 3.8: Western blot analysis confirmation of the over-expression of Hsp27, TIP41 and RhoE in transfected 
H9c2 cells. The first lane shows the control (untransfected H9c2) which indicated no expression, whereas the 
transfected H9c2 cells (H9c2-Hsp27, H9c2-TIP41 and H9c2-RhoE) show expression. The Western blot was 
performed once. 
 
The result in Figure 3.8 confirmed the over-expression of the three mutant cell lines. 
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3.4. Evaluating the susceptibility of the transfected cells to cell death 
 
3.4.1 Introduction 
Apoptosis, also referred to as programmed cell death is an important process which plays a 
crucial role in various other processes, such as normal cell turnover, normal development and 
functioning of the immune system, the removal of disinclined cells and maintenance of 
homeostasis (Reed and Tomaselli, 2000; Elmore, 2007). Apoptosis can be induced in response to 
various stimuli, which include heat stress, oxidative stress and genotoxic stress (Nagata, 1997).  
There are various compounds with the ability to induce apoptosis in vitro such as ceramide and 
camptothecin. Ceramide (N-Acyl-Sphingosine) is a sphingophospholipid a component of the cell 
membrane (Cock et al., 1998). Ceramide is known as a sphingolipid which is produced primarily 
from sphingomyellin by sphingomyellinases.  Ceramide is a lipid located in the cell membrane, 
which has been proposed as a signaling molecule with the ability to translate extracellular 
stresses to intracellular signals (Kondo et al., 2000).  It has been established that the metabolism 
of sphingolipids leads to active signals which has an influence on cell proliferation, 
differentiation and apoptosis. Of the latter metabolites, ceramide and sphingosine has been 
intensively studied. Ceramide is known as an anti-proliferative compound which promotes cell 
death and inhibits cell growth (Hannun and Bell, 1989). 
Camptothecin, a compound extracted from the Chinese tree Camptotheca acuminate is an 
inhibitor of topoisomerase I. Topoisomerase I (TOP1) is a ubiquitous enzyme required for the 
synthesis of DNA during replication, recombination and transcription (Tse et al., 1980).  
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It has been demonstrated that camptothecin can induce apoptosis in vitro, and is routinely 
utilized as an apoptotic inducer in vitro. Camptothecin is known to have anti-tumour activity due 
to its association with TOP1. TOP1 binds to DNA through a phosphatyrosine bond, and in turn 
promoting the cleavage of DNA, leading to the unwinding of DNA. Camptothecin inhibits the 
religation of DNA by binding to DNA, forming a enzyme:DNA complex (Hsiang et al., 1985). 
 
The objective of this section was to treat wild type H9c2 cells and the three mutant cell lines 
(H9c2-RhoE, H9c2-TIP41 and H9c2-Hsp27) with ceramide and camptothecin over a period of     
24 hours and assess the viability of the cells by the MTT assay. MTT is a widespread colormetric 
assay used to assess cell viability through the mitochondria. This assay does not differentiate 
between apoptosis and general toxicity. MTT dye enters the cells where it passes through the 
mitochondria and is reduced to an insoluble formazan product. Since MTT can only be reduced 
in metabolically active cells it is a measure of the viability of the cells (Mueller et al., 2004). 
 
3.4.2. Susceptibility of mutant cell lines to ceramide and camptothecin 
Wild type and the mutant H9c2 (H9c2-RhoE, H9c2-TIP41 and H9c2-Hsp27) cells were cultured 
until confluency was reached. The cells were seeded into 96-well plates and treated with 
ceramide and camptothecin for 24 hours as described in Section 2.13. The viability of the cells 
was measured with the use of the MTT assay.  
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Figure 3.9: Evaluation of the viability of cells that stably over-express RhoE, TIP41 and Hsp27. (A) shows mutant H9c2 cells treated with ceramide and 
camptothecin (B) for 24 hours. (A) indicates ~38% cell viability of H9c2 cells that over-express Hsp27 compared to ~22% viability of H9c2 control sample. (B) 
shows ~70% cell viability of H9c2 cells that over-express RhoE, compared to ~40% cell viability in H9c2 control sample.
 
 
 
 
75 
 
The result in Figure 3.9 indicates that the viability of H9c2-RhoE expressing cells are higher 
compared to H9c2-TIP41 and H9c2-Hsp27 in response to camptothecin induced cell death.  
 
3.4.3. Susceptibility of heat shock preconditioned H9c2 cells to ceramide and camptothecin 
H9c2 cells were cultured until confluency was reached the cells were subjected to heat shock 
pretreatment, at 42°C for an hour as described in Section 2.14.1. These cells were treated with 
ceramide and camptothecin for 24 hours and the viability of the cells was measured with the use 
of the MTT assay. 
 
 
 
 
76 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Evaluation of cell viability of preconditioned H9c2 cells. (A) shows preconditioned H9c2 cells treated with ceramide and (B) camptothecin  for 24 
hours. (A) shows ~17% viability of H9c2 preconditioned cells (2 hour recovery) and H9c2 preconditioned cells (4 hour recovery). 
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3.5.   Assessing differential protein expression in pcDNA3.1-RhoE transfected cells. 
 
3.5.1. Introduction 
Two dimensional gel electrophoresis (2D SDS-PAGE) is a technique that can be used to separate 
thousands of proteins with the aim of their consequent identification and quantitative 
comparison. This approach requires the quantitative analysis of various sets of gels in order to 
demonstrate differential protein expression (Marengo et al., 2005). Biological replicates are 
imperative for proteomic comparatives studies in order to visualize consistency in their protein 
expression and character profiles. The efficient use of 2D technique is dependant on data 
analysis software. PDQuest is software which is used for imaging, analysis and data basing 2D 
gels (Rosengran et al., 2003). The latter dates back to 1979, therefore it is one of the oldest 
software packages. PDQuest allows for statistical analysis of protein expression profiles and 
therefore is an important tool in statistically identifying proteins (Marengo et al., 2005). 
 
Since H9c2 cells that were shown to over-express RhoE also demonstrate resistance to 
camptothecin induced cell death, H9c2-RhoE cells were used in a comparative study in which 
the proteomes of H9c2 and H9c2-RhoE were compared. The latter would be compared with the 
use of 2D SDS-PAGE and differentially expressed proteins would be identified by the use of 
PDQuest software. Thereafter the identified spots would be cut and identified with the use of the 
mass spectrometry. 
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3.5.2. Two dimensional gel   electrophoresis of H9c2 and H9c2-RhoE proteomes. 
Three 25cm
2
 flasks of H9c2 and three 25cm
2
 flasks of H9c2-RhoE cells were cultured until 
confluency. Total protein lysates were prepared from the 6 flasks with the use of CytoBuster 
Extraction Reagent as described in Section 2.13. The extracted proteins were precipitated with 
the use of acetone as described in Section 2.20. The proteins were quantified with the use of the 
Bradford assay as described in Section 2.19.2. The total protein lysates (100µg) of H9c2 and 
H9c2-RhoE cells were separated by 2D SDS-PAGE as described in Section 2.20. The proteins 
were initially focused on IPG strips with the pH range of 4 to 7 according to their respective pI 
charges. The focused proteins were further separated in the second dimension (Figure 3.11) 
based to their molecular weight and stained with coomassie brilliant blue R-250 (Bio-Rad). 
 
 
 
 
Figure 3.11: 2D profile of H9c2 (A) and H9c2-RhoE (B) proteomes. The letter M on the top left of each gel 
represents the protein molecular weight marker. Proteins were separated in the range of pH 4 – 7. The protein spots 
of H9c2 and H9c2-RhoE proteomes appear similar with some differences. The figure shows a wide spread of protein 
spots at both high and low molecular weight and at both pH 4 and 7.  
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The spots represented in Figure 3.11 (A) and (B) represent single protein spots, and minimal 
smearing of the gel, the overall proteomes are similar with some differences. 
 
3.5.4. Analysis of protein expression profile of H9c2 and H9c2-RhoE. 
 
The computational software program, PDQuest was used as described in Section 2.21. Master 
gel was generated based on the protein spots present on the biological replicate gels H9c2 and 
H9c2-RhoE lysates. Qualitative, quantitative and a statistical T-Test set (p < 0.05), were 
performed on the protein spots to identify proteins that were differentially expressed between 
H9c2 and H9c2-RhoE.  
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Figure 3.12: Selected spots for (A) H9c2 and (B) H9c2-RhoE proteomes for identification by MALDI-TOF mass 
spectrometry. The letter M on the top left of each gel represents the protein molecular weight marker. Proteins were 
separated in the range of pH 4 – 7 In (A) H9c2 and (B) H9c2-RhoE, protein spots are widely spread at both high and 
low molecular weight. 
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The T-Test analysis set for both H9c2 and H9c2-RhoE samples was set up based on a 95% 
significance level. A total of 25 differentially expressed protein spots were present in the T-Test 
set, and 5 spots accounted for qualitative and 20 quantitative protein spots at 95% significance. 
Qualitative spots are spots only present in either the H9c2 or H9c2-RhoE sample but not both 
(Figure 3.13). Quantitative spots are those spots that are present in both H9c2 and H9c2-RhoE 
lysates, but the spot intensity (and therefore the expression level) is higher in the one sample 
compared to the other (Figure 3.14). 
 
 
 
 
 
 
 
 
 
Figure 3.13: Expression profile and representation of qualitative protein spot 4202 from wild type H9c2 proteome. 
The bar graph indicates the expression profile of spot 4202 with the use of PDQuest software. (A) shows the 
expression of spot 4202 in H9c2 proteome (indicated by red bars) but absent in H9c2-RhoE proteome. (B) and (C) 
shows a qualitative protein spot which is absent in H9c2-RhoE but present in H9c2 proteome. 
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Figure 3.14: Expression profile and representation of quantitative protein spot 7101 in H9c2 (B) and H9c2-RhoE 
(C). The green and red bars (A) shows differential expression between H9c2-RhoE (green bars) and H9c2 (red bars), 
where the expression level of spot 7101 is lower in H9c2-RhoE compared to H9c2. 
 
3.5.6. Protein spot selection and identification by MALDI-TOF mass spectrometry. 
 
A total of 20 differentially expressed proteins spots were cut out from H9c2 and H9c2-RhoE gels 
as described in Section 2.21.2. The protein spots are indicated in Figure 3.12. The protein spots 
were prepared for trypsinisation and identification by the matrix assisted laser 
desorption/ionisation time of flight (MALDI-TOF). The proteins which were cut had a 
differential expression profile of 95 % significance. Due to the fact that certain spots had weak 
intensities on the gel, only spots which were well resolved and high intensities were cut for the 
identification by MALDI-TOF mass spectrometry. 
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Table 3.1: Proteins identified by mass MALDI-TOF spectrometry 
Protein Spot Protein ID Protein Name 
SSP1502 Uncharacterized - 
SSP2203 Uncharacterized - 
SSP2303 Uncharacterized - 
SSP2402 gi|119581148 keratin 9 (epidermolytic 
palmoplantar keratoderma) 
SSP2503 Uncharacterized - 
SSP3202 gi|157830231 Chain A, Recombinant Rat 
Annexin V 
SSP3304 Uncharacterized - 
SSP3503 Uncharacterized - 
SSP4101 gi|31982030 Rho GDP-dissociation inhibitor α 
SSP4201 Uncharacterized - 
SSP4202 Uncharacterized - 
SSP5101 gi|245563 Apolipoprotein AI 
SSP5102 Uncharacterized - 
SSP5104 gi|424145 Heat shock protein 27 
SSP6201 Uncharacterized - 
SSP6401 gi|202549 Iodothyronine 5' monodeiodinase 
SSP7101 gi|94400790 Heat shock protein beta 1 
SSP8202 Uncharacterized - 
SSP8704 Uncharacterized - 
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Table 3.1 shows a list of statistically significant protein spots of which 7 were positively 
identified by mass MALDI-TOF spectrometry. 
 
3.6. Summary 
 
This research shows that RhoE, TIP41 and the well known heat shock protein Hsp27 are induced 
in response to heat shock. RhoE, TIP41 and Hsp27 were successfully cloned into the mammalian 
expression vector, pcDNA
™
3.1D/V5-His-TOPO. These constructs were successfully transfected 
into H9c2 cells, therefore generating three mutant cell lines (H9c2-RhoE, H9c2-TIP41 and 
H9c2-Hsp27). Furthermore the MTT assay data indicated that RhoE had a high cell viability 
compared to the other over-expressing mutant. Two dimensional gel electrophoresis was 
successfully carried out and 25 differentially expressed spots were selected with the use of the 
PDQuest software. Twenty of the 25 spots were cut and 7 proteins identified with the use of 
mass spectrometry. 
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CHAPTER 4: DISCUSSION 
The objective of this study was to investigate whether the induction of RhoE and TIP41 
following heat stress have any cytoprotective role in protecting H9c2 cardiomyocyte cells against 
cell death and to decipher a potential mechanism of cytoprotection. In order to gain more insight 
into the role these proteins play, we over-expressed RhoE and TIP41 in rat cardiomyocyte cells 
and analyzed the effect these proteins had on the cells in response to induced cell death. 
Proteomic tools were employed to investigate how the over-expression of these proteins affect 
the proteome of the cell lines. 
4.1 RhoE and TIP41 is induced by heat shock 
A previous study demonstrated by preconditioning of H9c2 cells at 42°C for an hour, resulted in 
the induction of various heat shock responsive genes. Among these genes were RhoE and TIP41 
(Gill, 2004). H9c2 cells were subjected to heat shock pre-treatment at 42°C for an hour. 
Thereafter the cells were allowed to recover at 37°C and RNA was extracted. Suppression 
Subtractive Hybridization was used to identify genes that are differentially expressed in response 
to heat stress. However it is not known if the proteins that are encoded by these genes are also 
induced by heat stress.  On the other hand it has been shown that TIP41 is induced in response to 
high salt stress conditions in yeast cells (Melamed et al., 2008).  RhoE has been shown to be 
upregulated in response to various factors, such as platelet derived growth factor (Riento et al., 
2003), hepatocyte growth factor (Tanimura et al., 2002) and upon the activation of Raf in 
MDCK cells (Hansen et al., 2000).  
In Figure 3.1 the unstressed control cells RhoE and TIP41 showed low level expression. 
However, Hsp27 could not be detected in unstressed cells. A reason for this could be that the 
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expression level of Hsp27 is generally very low in unstressed cells (Concannon et al., 2003) and 
is induced in response to stress insults such as heat shock  pre-treatment (Concannon et al., 
2003). In Figure 3.1 RhoE and TIP41 show a gradual increase in expression at various time 
points, whereas Hsp27 indicated induced expression only at 1 and 6 hours. The fact that Hsp27 
only indicated expression at 1 and 6 hours could account for a transient increase in Hsp27 in 
which it fulfilled its function as a chaperone, and thereafter the expression level decreases. To 
date there is no published literature which demonstrates that RhoE and TIP41 are induced or play 
a role in the heat shock response.  
 
4.2 RhoE protects H9c2 cells against camptothecin induced cell death. 
In order to investigate the potential cytoprotective effect of RhoE and TIP41, the genes encoding 
RhoE, TIP41 and Hsp27 were PCR amplified. The PCR products were successfully cloned into 
pcDNA
™
3.1D/V5-His-TOPO. Cloning was confirmed by sequence analysis. The sequence 
analysis data in Figure 3.5 shows pairwise protein sequence alignment of the sequence obtained 
for the PCR products and the expected protein sequences obtained from the NCBI database. 
RhoE and TIP41 showed 100% match with the expected sequence from the NCBI database. 
Hsp27 showed a 99% match. Two mutations were detected in the Hsp27 protein sequence 
obtained. These mutations may potentially affect the protein function. Plasmid DNA for the three 
constructs (pcDNA 3.1-RhoE, pcDNA 3.1-TIP41 and pcDNA 3.1-Hsp27) were prepared by 
cesium chloride gradient centrifugation. H9c2 cells were transfected with these plasmids.  
Figure 3.7 demonstrates that the constructs for RhoE, TIP41 and Hsp27 are successfully 
transfected. It is clear that the untransfected cells were not able to survive the G418 selection, 
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while the cells transfected with pcDNA 3.1-RhoE, pcDNA 3.1-TIP41 and pcDNA 3.1-Hsp27 
were able to grow in G418 selective media. To confirm that the cells over-express the proteins, 
total proteins were isolated from the cells and the expression levels were assessed by Western 
blot analysis. Western blot analysis data in Figure 3.8 demonstrates the over-expression of 
Hsp27, TIP41 and RhoE.  
To investigate whether the over-expression of RhoE and TIP41 has any cytoprotective role, the 
cells were treated with pro-apoptotic inducers, ceramide and camptothecin for 24 hours and cell 
viability was assessed by the MTT assay. The MTT assay is a cell viability assay which employs 
a colorimetric assay system which measures the reduction of the MTT dye by the mitochondria 
in viable cells to a blue insoluble formazan product. The addition of an organic solvent (DMSO) 
converts the insoluble formazan product to a soluble product which can be analyzed by a 
platereader at 560nm (Mueller et al., 2004). The mutant cells, H9c2-RhoE and H9c2-TIP41 
showed no cytoprotection upon treatment with ceramide. However, cells over-expressing Hsp27 
(H9c2-Hsp27) showed cytoprotection in response to treatment with 250µM ceramide. 
Interestingly H9c2-Hsp27 cells were not protected against camptothecin induced cell death. Cells 
over-expressing RhoE (H9c2-RhoE) showed resistance to camptothecin induced cell death. The 
viability of H9c2-RhoE cells treated with 250µM camptothecin was ~70% compared to ~40% in 
the H9c2 control. The result in Figure 3.10 shows ~90% and ~75% cell viability of H9c2 
preconditioned cells at 2 hour recovery period in response to treatment with 250µM and            
500 µM camptothecin respectively. This result correlated with the viability of RhoE expressing 
cells which showed cell viability of ~70%, where most likely RhoE and other proteins are up-
regulated in the preconditioned cells. The reasons for differences between H9c2-Hsp27 and 
H9c2-RhoE in response to ceramide and camptothecin treatment can be that ceramide and 
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camptothecin activate different apoptotic pathways. The over-expression of Hsp27 and RhoE is 
likely to affect different pathways and as a result the mutant cells respond differently.  
 
4.3. The over-expression of RhoE leads to the down-regulation of Rho GDP-dissociation 
inhibitor I protein 
As previously discussed this research shows that the induction of RhoE leads to cytoprotection in 
response to camptothecin induced cell death, whereas TIP41 showed no signs of cytoprotection. 
Therefore, the focus was on H9c2-RhoE mutant cells. In order to investigate a potential 
mechanism by which RhoE enables cytoprotection, H9c2 and H9c2-RhoE proteomes were 
compared for differential protein expression. To achieve this, total proteins from H9c2 and    
H9c2-RhoE cells was isolated and the lysates quantified by the Bradford assay. The proteomes 
(H9c2 and H9c2-RhoE) were compared by separation with the use of two dimensional         
SDS-PAGE gel electrophoresis. Figure 3.11 showed a widespread of protein spots in the 
proteomes of H9c2 and H9c2-RhoE, separated in the second dimension at both high and low 
molecular weight, and across a pH range of 4 to 7. Twenty statistically significant (95%) spots 
were excised from the gels of which 7 were positively identified by MALDI-TOF mass 
spectrometry (Table 3.1). Table 3.1 shows the twenty statistically significant spots of which 7 
proteins were identified of which one can possibly be linked to RhoE. Our study shows that the 
over-expression of RhoE results in the down-regulation of Rho GDP-dissociation inhibitor I 
(Rho-GDI α) (Data not shown). String (www.string-db.org), a bioinformatic tool suggested a 
protein-protein interaction between Rho-GDI α and RhoE by textmining. Furthermore, Rho-GDI 
α is a known negative regulator of Rho proteins, where a study conducted by Ying-Xin et al 
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(2008) suggested that a decrease in Rho-GDI α may lead to the activation of Rho proteins during 
vascular remodelling. The study by Ying-Xin et al (2008) also suggests that low shear stress in 
smooth muscle cells leads to the induction of apoptosis and consequently a decreased expression 
of Rho-GDI α. RhoE leads to the down-regulation of Rho-GDI α and according to the literature 
described, we can speculate that possibly the decreased expression of Rho-GDI α could lead to 
the induction of cell death (as described in Ying-Xin et al (2008)), however there could possibly 
be a feedback loop from RhoE to Rho-GDI α which enables RhoE to inhibit camptothecin 
induced cell death.  
 
4.4 Conclusion 
In this study we have demonstrated that RhoE, TIP41 and Hsp27 are induced in response to heat 
shock pre-treatment and that the over-expression RhoE leads to the inhibition of cell death 
(cytoprotection). We can also speculate that based on the MTT data that Hsp27 and RhoE are 
likely to affect two different pathways as the mutant cells respond differently in response to 
ceramide and camptothecin induced cell death. Furthermore, we demonstrated that the           
over-expression of RhoE resulted in the down-regulation of Rho GDP-dissociation inhibitor α.  
4.5 Future directions 
4.5.1. Limitations of the study 
The present study has certain limitations which need to be taken into account. Although     
pcDNA 3.1-Hsp27 was successfully transfected into H9c2 cells and was shown to be            
over-expressed, the mutations in the sequence analysis data could possibly affected the function 
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of the protein. The latter could possibly account for the level of cytoprotection shown by Hsp27. 
We analyzed cell viability by the MTT assay, however this assay does not differentiate between 
apoptosis and cytotoxcity tests, therefore, an apoptosis assay needs to be performed in order to 
give more clarity with regard to the role RhoE plays in protecting rat cardiomyocytes against cell 
death. Another limitation is that we were only able to positively identify 50% of the proteins by 
mass spectrometry, therefore by repeating and successfully identifying more protein this could 
possibly give more insight into the role RhoE plays in protecting rat cardiomyocyte cells against 
camptothecin induced cell death. 
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